CAS 147098-20-2 | 6-Heptenoic acid, 7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E)- | CAS Number 147098-20-2

Title	Journal
Inhibition and stimulation of the human breast cancer resistance protein as in vitro predictor of drug-drug interactions of drugs of abuse.	Archives of toxicology 20180901
Why are most phospholipidosis inducers also hERG blockers?	Archives of toxicology 20171201
Effects of diosmetin on nine cytochrome P450 isoforms, UGTs and three drug transporters in vitro.	Toxicology and applied pharmacology 20171101
Ascorbic acid supplementation partially prevents the delayed reproductive development in juvenile male rats exposed to rosuvastatin since prepuberty.	Reproductive toxicology (Elmsford, N.Y.) 20171001
Rosuvastatin safety: An experimental study of myotoxic effects and mitochondrial alterations in rats.	Toxicology letters 20170104
The Antimicrobial Agent Fusidic Acid Inhibits Organic Anion Transporting Polypeptide-Mediated Hepatic Clearance and May Potentiate Statin-Induced Myopathy.	Drug metabolism and disposition: the biological fate of chemicals 20160501
Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice.	PloS one 20160101
Optimized Hepatocyte-Like Cells with Functional Drug Transporters Directly-Reprogrammed from Mouse Fibroblasts and their Potential in Drug Disposition and Toxicology.	Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20160101
Transmembrane transport of steviol glucuronide and its potential interaction with selected drugs and natural compounds.	Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20151201
Clinical drug interaction profile of idelalisib in healthy subjects.	Journal of clinical pharmacology 20150801
Statins alter the hepatobiliary transport of unconjugated and conjugated bilirubin in sandwich-cultured rat hepatocytes.	Toxicology in vitro : an international journal published in association with BIBRA 20140901
Quercetin-3-rhamnoglucoside (rutin) stimulates transport of organic anion compounds mediated by organic anion transporting polypeptide 2B1.	Biopharmaceutics & drug disposition 20140401
Detection of statin cytotoxicity is increased in cells expressing the OATP1B1 transporter.	Toxicological sciences : an official journal of the Society of Toxicology 20130701
ATP-dependent transport of statins by human and rat MRP2/Mrp2.	Toxicology and applied pharmacology 20130601
Disposition of atorvastatin, rosuvastatin, and simvastatin in oatp1b2-/- mice and intraindividual variability in human subjects.	Journal of clinical pharmacology 20121101
Intronic variants in SLCO1B1 related to statin-induced myopathy are associated with the low-density lipoprotein cholesterol response to statins in Chinese patients with hyperlipidaemia.	Pharmacogenetics and genomics 20121101
Rosuvastatin improves vascular function of arteriovenous fistula in a diabetic rat model.	Journal of vascular surgery 20121101
The role of a basolateral transporter in rosuvastatin transport and its interplay with apical breast cancer resistance protein in polarized cell monolayer systems.	Drug metabolism and disposition: the biological fate of chemicals 20121101
Interaction between SNPs in the RXRA and near ANGPTL3 gene region inhibits apoB reduction after statin-fenofibric acid therapy in individuals with mixed dyslipidemia.	Journal of lipid research 20121101
Total cholesterol content of erythrocyte membranes is associated with the severity of coronary artery disease and the therapeutic effect of rosuvastatin.	Upsala journal of medical sciences 20121101
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: a possible compensatory mechanism.	Nutrition, metabolism, and cardiovascular diseases : NMCD 20121001
Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease.	Cardiovascular therapeutics 20121001
Effect of statins on coronary bifurcation atherosclerosis: an intravascular ultrasound virtual histology study.	The international journal of cardiovascular imaging 20121001
Single-dose, 2-way crossover, bioequivalence study of two rosuvastatin formulations in normal healthy subjects under fasting conditions.	International journal of clinical pharmacology and therapeutics 20121001
Differences in synthesis and absorption of cholesterol of two effective lipid-lowering therapies.	Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20121001
Effect of rosuvastatin on the echolucency of the common carotid intima-media in low-risk individuals: the METEOR trial.	Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 20121001
Long-term effects of ezetimibe-plus-statin therapy on low-density lipoprotein cholesterol levels as compared with double-dose statin therapy in patients with coronary artery disease.	Atherosclerosis 20121001
Rosuvastatin may modulate insulin signaling and inhibit atherogenesis beyond its plasma cholesterol-lowering effect in insulin-resistant mice.	Cardiovascular drugs and therapy 20121001
Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: role of iNOS and VEGF.	European journal of pharmacology 20120915
Effects of rosuvastatin versus pravastatin on low-density lipoprotein diameter in HIV-1-infected patients receiving ritonavir-boosted protease inhibitor.	AIDS (London, England) 20120910
The therapeutic effect of rosuvastatin on cardiac remodelling from hypertrophy to fibrosis during the end-stage hypertension in rats.	Journal of cellular and molecular medicine 20120901
Use of uptake intrinsic clearance from attached rat hepatocytes to predict hepatic clearance for poorly permeable compounds.	Xenobiotica; the fate of foreign compounds in biological systems 20120901
Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study.	European heart journal 20120901
Use of mechanistic modeling to assess interindividual variability and interspecies differences in active uptake in human and rat hepatocytes.	Drug metabolism and disposition: the biological fate of chemicals 20120901
Comparison of the effects of different statins and doses on lipid levels in patients with diabetes: results from VOYAGER.	Nutrition, metabolism, and cardiovascular diseases : NMCD 20120901
Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression.	Oncology reports 20120901
Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.	European journal of heart failure 20120901
Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome.	International journal of clinical practice 20120901
Chronic exposure to environmental contaminant nonylphenol exacerbates adenine-induced chronic renal insufficiency: role of signaling pathways and therapeutic impact of rosuvastatin.	European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20120815
Caveolin-1-eNOS/Hsp70 interactions mediate rosuvastatin antifibrotic effects in neonatal obstructive nephropathy.	Nitric oxide : biology and chemistry 20120815
Balancing the cardiometabolic benefits and risks of statins.	Lancet (London, England) 20120811
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial.	Lancet (London, England) 20120811
Drug interaction profile for GSK2248761, a next generation non-nucleoside reverse transcriptase inhibitor.	British journal of clinical pharmacology 20120801
Rosuvastatin suppresses the liver microsomal CYP2C11 and CYP2C6 expression in male Wistar rats.	Xenobiotica; the fate of foreign compounds in biological systems 20120801
MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression.	Clinical science (London, England : 1979) 20120801
Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level.	Metabolism: clinical and experimental 20120801
Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet.	Clinical science (London, England : 1979) 20120801
Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.	Journal of cardiovascular pharmacology 20120801
CD11b+ bone marrow-derived monocytes are the major leukocyte subset responsible for retinal capillary leukostasis in experimental diabetes in mouse and express high levels of CCR5 in the circulation.	The American journal of pathology 20120801
Predictive value of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio for the prevention of stroke recurrence in Japanese patients treated with rosuvastatin.	Clinical drug investigation 20120801
Effects of statin treatments and polymorphisms in UGT1A1 and SLCO1B1 on serum bilirubin levels in Chinese patients with hypercholesterolaemia.	Atherosclerosis 20120801
Effect of intensive lipid-lowering treatment compared to moderate lipid-lowering treatment with rosuvastatin on endothelial function in high risk patients.	International journal of cardiology 20120726
Rosuvastatin combined with ramipril significantly reduced atheroma volume by anti-inflammatory mechanism: comparative analysis with rosuvastatin alone by intravascular ultrasound.	International journal of cardiology 20120712
Cardioprotective effects of rosuvastatin and carvedilol on delayed cardiotoxicity of doxorubicin in rats.	Toxicology mechanisms and methods 20120701
Rosuvastatin improves pulse wave reflection by restoring endothelial function.	Microvascular research 20120701
The farnesoid X receptor -1G>T polymorphism influences the lipid response to rosuvastatin.	Journal of lipid research 20120701
Simultaneous and spontaneous bilateral quadriceps tendons rupture.	American journal of physical medicine & rehabilitation 20120701
Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy.	Atherosclerosis 20120701
Non-every day statin administration--a literature review.	European journal of internal medicine 20120701
Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.	Pharmacotherapy 20120701
Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in female patients with non-ST-segment elevation acute coronary syndrome.	Chinese medical journal 20120701
Rosuvastatin slows the development of diastolic dysfunction in calcific aortic stenosis.	The Journal of heart valve disease 20120701
Pharmacokinetic interactions between clopidogrel and rosuvastatin: effects on vascular protection in subjects with coronary heart disease.	International journal of cardiology 20120628
The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3).	EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20120620
Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial).	The American journal of cardiology 20120615
Change in near-infrared spectroscopy of a coronary artery after 1-year treatment with high dose rosuvastatin.	International journal of cardiology 20120614
[Effects of domestic rosuvastatin on coronary plaque in patients with mild-to-moderate coronary artery stenosis as evaluated by virtual histology-intravascular ultrasound].	Zhonghua yi xue za zhi 20120612
[Effectiveness of generic rosuvastatin in patients with ischaemic cerebrovascular disease].	Orvosi hetilap 20120603
Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy?	European journal of preventive cardiology 20120601
Steady-state pharmacokinetic interactions of darunavir/ritonavir with lipid-lowering agent rosuvastatin.	Journal of clinical pharmacology 20120601
Multiple imputation of missing repeated outcome measurements did not add to linear mixed-effects models.	Journal of clinical epidemiology 20120601
Biologically implausible carotid intima-media thickness measurement values: effects on rate of change over time.	Current medical research and opinion 20120601
A review of time courses and predictors of lipid changes with fenofibric acid-statin combination.	Cardiovascular drugs and therapy 20120601
Rosuvastatin effect on intima media thickness in adult vs elderly patients.	Frontiers in bioscience (Elite edition) 20120601
Severe hypertriglyceridaemia. Treatment with plasmapheresis.	Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20120514
Expression of let-7i is associated with Toll-like receptor 4 signal in coronary artery disease: effect of statins on let-7i and Toll-like receptor 4 signal.	Immunobiology 20120501
[Extrapolating the NNT jeopardises biostatistics and leads to immortality].	Atencion primaria 20120501
Effects of rosuvastatin and atorvastatin on glycaemic control in Type 2 diabetes---the CORALL study.	Diabetic medicine : a journal of the British Diabetic Association 20120501
The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*.	Journal of internal medicine 20120501
Statins improve outcome in murine models of intracranial hemorrhage and traumatic brain injury: a translational approach.	Journal of neurotrauma 20120501
Comparison of lipid-modifying efficacy of rosuvastatin versus atorvastatin in patients with acute coronary syndrome (from the LUNAR study).	The American journal of cardiology 20120501
Relationship of lipoprotein-associated phospholipase A₂ mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: an analysis from the JUPITER trial.	Clinical chemistry 20120501
Sample size requirements in trials using repeated measurements and the impact of trial design.	Current medical research and opinion 20120501
Statins and glycaemic control--a cause for concern?	Diabetic medicine : a journal of the British Diabetic Association 20120501
Rosuvastatin might have an effect on C-reactive protein but not on rheumatoid disease activity: Tayside randomized controlled study.	Scottish medical journal 20120501
On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).	Journal of the American College of Cardiology 20120424
The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial.	CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20120417
Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared to rosuvastatin 10 mg in high-risk patients with and without type 2 diabetes mellitus inadequately controlled despite prior statin monotherapy.	Cardiovascular therapeutics 20120401
Metabolic stress-induced inflammation plays a major role in the development of osteoarthritis in mice.	Arthritis and rheumatism 20120401
Understanding the interplay of drug transporters involved in the disposition of rosuvastatin in the isolated perfused rat liver using a physiologically-based pharmacokinetic model.	Xenobiotica; the fate of foreign compounds in biological systems 20120401
Effects of rosuvastatin on serum asymmetric dimethylarginine levels and atrial structural remodeling in atrial fibrillation dogs.	Pacing and clinical electrophysiology : PACE 20120401
One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response.	American journal of cardiovascular drugs : drugs, devices, and other interventions 20120401
Renal safety of intensive cholesterol-lowering treatment with rosuvastatin: a retrospective analysis of renal adverse events among 40,600 participants in the rosuvastatin clinical development program.	Atherosclerosis 20120401
Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.	Circulation. Cardiovascular genetics 20120401
Effects of HMG-CoA reductase inhibitor on experimental autoimmune myocarditis.	Cardiovascular drugs and therapy 20120401
Targeting HDL-cholesterol to reduce residual cardiovascular risk.	Current opinion in lipidology 20120401
Reversible dysphasia and statins.	Journal of Korean medical science 20120401
Rosuvastatin attenuates mucus secretion in a murine model of chronic asthma by inhibiting the gamma-aminobutyric acid type A receptor.	Chinese medical journal 20120401
Atorvastatin, not rosuvastatin, improves cardiac function in heart failure: a meta-analysis of randomized trials.	International journal of cardiology 20120308
Manual or semi-automated edge detection of the maximal far wall common carotid intima-media thickness: a direct comparison.	Journal of internal medicine 20120301
The effects of rosuvastatin and the CYP51A1 inhibitor LEK-935 on the proteome of primary human hepatocytes.	Drug metabolism and disposition: the biological fate of chemicals 20120301
Rosuvastatin elicits KDR-dependent vasculogenic response of human placental stem cells through PI3K/AKT pathway.	Pharmacological research 20120301
Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study.	Current medical research and opinion 20120301
Non-lipid effects of rosuvastatin-fenofibrate combination therapy in high-risk Asian patients with mixed hyperlipidemia.	Atherosclerosis 20120301
Therapeutic options for statin-intolerant patients.	Current medical research and opinion 20120301
The work-up for mixed hyperlipidemia: a case study.	The Journal of family practice 20120301
Effect of rosuvastatin on obesity-induced cardiac oxidative stress in Wistar rats--a preliminary study.	Indian journal of experimental biology 20120301
The importance of green chemistry in process research and development.	Chemical Society reviews 20120221
Proprotein convertase substilisin/kexin type 9 antagonism reduces low-density lipoprotein cholesterol in statin-treated hypercholesterolemic nonhuman primates.	The Journal of pharmacology and experimental therapeutics 20120201
Differential modulation of cytochrome P450 activity and the effect of 1-aminobenzotriazole on hepatic transport in sandwich-cultured human hepatocytes.	Drug metabolism and disposition: the biological fate of chemicals 20120201
Rosuvastatin blocks hERG current and prolongs cardiac repolarization.	Journal of pharmaceutical sciences 20120201
Efficacy and safety of coadministration of rosuvastatin, ezetimibe, and colestimide in heterozygous familial hypercholesterolemia.	The American journal of cardiology 20120201
Effect of pitavastatin vs. rosuvastatin on international normalized ratio in healthy volunteers on steady-state warfarin.	Current medical research and opinion 20120201
High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial.	European heart journal 20120201
Pharmacogenetic determinants of statin-induced reductions in C-reactive protein.	Circulation. Cardiovascular genetics 20120201
[HDL level or HDL function as the primary target in preventive cardiology].	Herz 20120201
My patient has an elevated hs-CRP. What does this mean? What should I do now?	JPMA. The Journal of the Pakistan Medical Association 20120201
Impact of 10 mg rosuvastatin daily or alternate-day on lipid profile and inflammatory markers.	Clinica chimica acta; international journal of clinical chemistry 20120118
A meta-analysis of randomized head-to-head trials of atorvastatin versus rosuvastatin for reductions in C-reactive protein.	International journal of cardiology 20120112
Enhancement of antioxidant defense mechanism by pitavastatin and rosuvastatin on obesity-induced oxidative stress in Wistar rats.	Toxicology mechanisms and methods 20120101
Short-term statin treatment does not prevent ischemia and reperfusion-induced endothelial dysfunction in humans.	Journal of cardiovascular pharmacology 20120101
Extensive or restricted ultrasound protocols to measure carotid intima-media thickness: analysis of completeness rates and impact on observed rates of change over time.	Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 20120101
Loss of the preconditioning effect of rosuvastatin during sustained therapy: a human in vivo study.	American journal of physiology. Heart and circulatory physiology 20120101
Cost-effectiveness of rosuvastatin 20 mg for the prevention of cardiovascular morbidity and mortality: a Swedish economic evaluation of the JUPITER trial.	Journal of medical economics 20120101
Rosuvastatin, proprotein convertase subtilisin/kexin type 9 concentrations, and LDL cholesterol response: the JUPITER trial.	Clinical chemistry 20120101
Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: Justification for Atherosclerosis Regression Treatment (JART) study.	Circulation journal : official journal of the Japanese Circulation Society 20120101
Intensive lipid-lowering therapy with statins for primary prevention.	Circulation journal : official journal of the Japanese Circulation Society 20120101
A simple assay for the simultaneous determination of rosuvastatin acid, rosuvastatin-5S-lactone, and N-desmethyl rosuvastatin in human plasma using liquid chromatography-tandem mass spectrometry (LC-MS/MS).	Analytical and bioanalytical chemistry 20120101
Statins, plasma proprotein convertase subtilisin/kexin type 9 concentrations, and LDL lowering.	Clinical chemistry 20120101
Measuring carotid artery intima-media thickness: simplicity versus complexity?	Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 20120101
Rosuvastatin preserves renal structure following unilateral ureteric obstruction in the neonatal rat.	American journal of nephrology 20120101
β-conglycinin combined with fenofibrate or rosuvastatin have exerted distinct hypocholesterolemic effects in rats.	Lipids in health and disease 20120101
Rhabdomyolysis and acute renal failure following hard physical activity in a patient treated with rosuvastatin.	Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20120101
[Almanac 2011: Valvular heart disease. Review of select studies that have driven recent advances in clinical cardiology: in the care of the Editors' Network Task Force of the European Society of Cardiology].	Giornale italiano di cardiologia (2006) 20120101
The relation between serum lipids and lutein and zeaxanthin in the serum and retina: results from cross-sectional, case-control and case study designs.	Lipids in health and disease 20120101
Effects of rosuvastatin and atorvastatin on renal function: meta-analysis.	Circulation journal : official journal of the Japanese Circulation Society 20120101
Effects of some anti-diabetic and cardioprotective agents on proliferation and apoptosis of human coronary artery endothelial cells.	Cardiovascular diabetology 20120101
Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs.	PloS one 20120101
The effect of rosuvastatin in a murine model of influenza A infection.	PloS one 20120101
Rosuvastatin and the JUPITER trial: critical appraisal of a lifeless planet in the galaxy of primary prevention.	International journal of occupational and environmental health 20120101
Antibacterial activity of statins: a comparative study of atorvastatin, simvastatin, and rosuvastatin.	Annals of clinical microbiology and antimicrobials 20120101
Use of once-weekly statin in combination with ezetimibe in a patient with mitochondrial disease.	BMJ case reports 20120101
Rosuvastatin-induced pemphigoid.	BMJ case reports 20120101
Effect of rosuvastatin on ROCK activity, endothelial function, and inflammation in Asian patients with atherosclerosis.	Internal medicine (Tokyo, Japan) 20120101
LDL-induced impairment of human vascular smooth muscle cells repair function is reversed by HMG-CoA reductase inhibition.	PloS one 20120101
Adverse drug reaction: rosuvastatin as a cause for ischaemic colitis in a 64-year-old woman.	BMJ case reports 20120101
[The Saturn study].	Giornale italiano di cardiologia (2006) 20120101
Combination treatment of rosuvastatin or atorvastatin, with regular exercise improves arterial wall stiffness in patients with coronary artery disease.	PloS one 20120101
The high-dose rosuvastatin once weekly study (the HD-ROWS).	Journal of clinical lipidology 20120101
[Atorvastatin or rosuvastatin? Select from the perspective of evidence-based medicine].	Kardiologiia 20120101
A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class.	PloS one 20120101
[Case of purpura nephritis accompanied by idiopathic cholesterol embolism].	Nihon Jinzo Gakkai shi 20120101
[How to prolong life of patients at high cardiovascular risk. Features of rosuvastatin].	Kardiologiia 20120101
Comparative effects of high and low-dose simvastatin on prostate epithelial cells: the role of LDL.	European journal of pharmacology 20111230
[Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): -- the PATROL trial].	Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20111210
[Symptomatic coronary heart disease. Impressive plaque reduction with high dose statins].	MMW Fortschritte der Medizin 20111208
Statins for primary prevention of venous thromboembolism.	The Cochrane database of systematic reviews 20111207
The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia.	Expert opinion on pharmacotherapy 20111201
The effect of herbal medicine danshensu and ursolic acid on pharmacokinetics of rosuvastatin in rats.	European journal of drug metabolism and pharmacokinetics 20111201
Effect of 2-year treatment with low-dose rosuvastatin on intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease.	Expert opinion on pharmacotherapy 20111201
Effect of two intensive statin regimens on progression of coronary disease.	The New England journal of medicine 20111201
[Effects of different statins, ezetimibe/simvastatin combination on hsCRP levels in unstable angina pectoris and non-ST elevation myocardial infarction patients: a randomized trial].	Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20111201
[Achievement of therapeutic target in subjects on statin treatment in clinical practice. Results of the STAR (Statins Target Assessment in Real practice) study].	Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 20111201
Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.	JAMA 20111116
Simultaneous determination of timolol maleate, rosuvastatin calcium and diclofenac sodium in pharmaceuticals and physiological fluids using HPLC-UV.	Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20111115
Rosuvastatin does not affect human apolipoprotein A-I expression in genetically modified mice: a clue to the disputed effect of statins on HDL.	British journal of pharmacology 20111101
[Fibrillary nonamyloid glomerulonephritis: a rare etiology of nephrotic syndrome].	Nephrologie & therapeutique 20111101
Differential effect of statins on diabetic nephropathy in db/db mice.	International journal of molecular medicine 20111101
Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial.	Scandinavian journal of rheumatology 20111101
The human primary hepatocyte transcriptome reveals novel insights into atorvastatin and rosuvastatin action.	Pharmacogenetics and genomics 20111101
Algorithms to measure carotid intima-media thickness in trials: a comparison of reproducibility, rate of progression and treatment effect.	Journal of hypertension 20111101
Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance.	International journal of clinical practice 20111101
Drug safety evaluation of rosuvastatin.	Expert opinion on drug safety 20111101
Apolipoprotein B100 is a better treatment target than calculated LDL and non-HDL cholesterol in statin-treated patients.	Annals of clinical biochemistry 20111101
Clinical experience with rosuvastatin in the management of hyperlipidemia and the reduction of cardiovascular risk.	Expert review of cardiovascular therapy 20111101
[COSMOS (coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects) trial].	Nihon rinsho. Japanese journal of clinical medicine 20111101
Direct, metal-free amination of heterocyclic amides/ureas with NH-heterocycles and N-substituted anilines in POCl3.	The Journal of organic chemistry 20111021
Potential phototoxicity of rosuvastatin mediated by its dihydrophenanthrene-like photoproduct.	Chemical research in toxicology 20111017
Effect of rosuvastatin on hemoglobin levels in patients with anemia and low-grade inflammation: a post hoc analysis of the JUPITER trial.	Journal of clinical pharmacology 20111001
The JUPITER trial: myth or reality?	Current atherosclerosis reports 20111001
Lipid-altering efficacy of switching to ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk patients with and without metabolic syndrome.	Diabetes & vascular disease research 20111001
Renal toxicity of lisinopril and rosuvastatin, alone and in combination, in Wistar rats.	International journal of toxicology 20111001
Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation.	Journal of hypertension 20111001
[Rosuvastatin improves myocardial function and arteriosclerosis plaque in patients with ST-segment elevation after acute myocardial infarction and percutaneous coronary intervention].	Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20111001
I am a 60-year-old woman with CAD. My LDL is 64 and my HDL is 72 on Zocor, but my doctor thinks Crestor may be better for me. He says it is more potent and could reduce my numbers even more. I would have to pay for this drug out-of-pocket. Do you think the additional cost would be worth it?	Heart advisor 20111001
Rosuvastatin improves endothelial function in db/db mice: role of angiotensin II type 1 receptors and oxidative stress.	British journal of pharmacology 20110901
Cholesterol-independent neuroprotective and neurotoxic activities of statins: perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders.	Pharmacological research 20110901
Rosuvastatin attenuates monocrotaline-induced pulmonary hypertension via regulation of Akt/eNOS signaling and asymmetric dimethylarginine metabolism.	European journal of pharmacology 20110901
Culture period-dependent changes in the uptake of transporter substrates in sandwich-cultured rat and human hepatocytes.	Drug metabolism and disposition: the biological fate of chemicals 20110901
Rationale and design of STOP DVT study: rosuvastatin for the prevention of deep vein thrombosis in patients undergoing total knee replacement arthroplasty--a prospective randomized open-label controlled trial.	Contemporary clinical trials 20110901
Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study.	Lancet (London, England) 20110820
Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up-titration of rosuvastatin in patients with hypercholesterolemia (the ACTE Study).	The American journal of cardiology 20110815
Eltrombopag increases plasma rosuvastatin exposure in healthy volunteers.	British journal of clinical pharmacology 20110801
Statins prevent tissue factor induction by protease-activated receptors 1 and 2 in human umbilical vein endothelial cells in vitro.	Journal of thrombosis and haemostasis : JTH 20110801
Dose-dependent effect of rosuvastatin in the regulation of metalloproteinase expression.	Annals of vascular surgery 20110801
Radiation recall 5 years after whole-breast irradiation for early-stage breast cancer secondary to initiation of rosuvastatin and amlodipine.	Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110801
Rosuvastatin beneficially alters the glomerular structure of kidneys from spontaneously hypertensive rats (SHRs).	Journal of molecular histology 20110801
pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1.	Molecular pharmaceutics 20110801
Therapy and clinical trials: aggressive statin therapy versus combined and emerging approaches.	Current opinion in lipidology 20110801
HMG-CoA reductase inhibitors enhance phagocytosis by upregulating ATP-binding cassette transporter A7.	Atherosclerosis 20110801
Rosuvastatin blocks advanced glycation end products-elicited reduction of macrophage cholesterol efflux by suppressing NADPH oxidase activity via inhibition of geranylgeranylation of Rac-1.	Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20110801
A tale of three labels: translating the JUPITER trial data into regulatory claims.	Clinical trials (London, England) 20110801
A tale of five opinions (at least).	Clinical trials (London, England) 20110801
Regulatory divergence.	Clinical trials (London, England) 20110801
Translating study results to labeling.	Clinical trials (London, England) 20110801
Rosuvastatin prevents proteinuria and renal inflammation in nitric oxide-deficient rats.	Clinics (Sao Paulo, Brazil) 20110801
[Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].	Zhonghua xin xue guan bing za zhi 20110801
Anti-apoptotic potential of rosuvastatin pretreatment in murine model of cardiomyopathy.	International journal of cardiology 20110715
Effect of lipid-lowering treatment on natural history of heterozygous familial hypercholesterolemia in past three decades.	The American journal of cardiology 20110715
Determination of chamaechromone in rat plasma by liquid chromatography-tandem mass spectrometry: application to pharmacokinetic study.	Journal of pharmaceutical and biomedical analysis 20110715
Effects of rosuvastatin on progression of stenosis in adult patients with congenital aortic stenosis (PROCAS Trial).	The American journal of cardiology 20110715
Beneficial effects of rosuvastatin on aortic adverse remodeling in nitric oxide-deficient rats.	Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20110701
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.	Drug metabolism and disposition: the biological fate of chemicals 20110701
Rosuvastatin combined with regular exercise preserves coenzyme Q10 levels associated with a significant increase in high-density lipoprotein cholesterol in patients with coronary artery disease.	Atherosclerosis 20110701
The statin class of HMG-CoA reductase inhibitors demonstrate differential activation of the nuclear receptors PXR, CAR and FXR, as well as their downstream target genes.	Xenobiotica; the fate of foreign compounds in biological systems 20110701
Rosuvastatin induces apoptosis in cultured human papillary thyroid cancer cells.	The Journal of endocrinology 20110701
Statins exert differential effects on angiotensin II-induced atherosclerosis, but no benefit for abdominal aortic aneurysms.	Atherosclerosis 20110701
Rosuvastatin attenuates the elevation in blood pressure induced by overexpression of human C-reactive protein.	Hypertension research : official journal of the Japanese Society of Hypertension 20110701
Rosuvastatin in diabetic hemodialysis patients.	Journal of the American Society of Nephrology : JASN 20110701
CRP induces hypertension in animal models: homo sapiens says no.	Hypertension research : official journal of the Japanese Society of Hypertension 20110701
Sunrise of statins after AURORA and 4D?	Journal of the American Society of Nephrology : JASN 20110701
Rosuvastatin, a new generation 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, reduces ischemia/reperfusion-induced spinal cord tissue injury in rats.	Annals of vascular surgery 20110701
Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.	American heart journal 20110701
[Pharmaco-economic optimization of cholesterol-lowering treatment with statins].	Medicina clinica 20110625
What else does the JUPITER trial add regarding C-reactive protein and cardiovascular disease?	International journal of cardiology 20110616
Impact of statins on glucose metabolism--a matter of debate.	The American journal of cardiology 20110615
Effects of pravastatin and rosuvastatin on the generation of adiponectin in the visceral adipose tissue in patients with coronary artery disease.	Fundamental & clinical pharmacology 20110601
Effects of rosuvastatin on vascular biomarkers and carotid atherosclerosis in lupus: a randomized, double-blind, placebo-controlled trial.	Arthritis care & research 20110601
High doses of rosuvastatin are superior to low doses of rosuvastatin plus fenofibrate or n-3 fatty acids in mixed dyslipidemia.	Lipids 20110601
Genetic polymorphisms in Na+-taurocholate co-transporting polypeptide (NTCP) and ileal apical sodium-dependent bile acid transporter (ASBT) and ethnic comparisons of functional variants of NTCP among Asian populations.	Xenobiotica; the fate of foreign compounds in biological systems 20110601
Switching from statin monotherapy to ezetimibe/simvastatin or rosuvastatin modifies the relationships between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients at high risk of coronary disease.	Clinical biochemistry 20110601
Combining rosuvastatin with sartans of different peroxisome proliferator-activated receptor-γ activating capacity is not associated with different changes in low-density lipoprotein subfractions and plasma lipoprotein-associated phospholipase A₂.	Metabolic syndrome and related disorders 20110601
Impact of statins on progression of atherosclerosis: rationale and design of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: effect of Rosuvastatin versus AtorvastatiN).	Current medical research and opinion 20110601
Association between obesity, high-sensitivity C-reactive protein ≥2 mg/L, and subclinical atherosclerosis: implications of JUPITER from the Multi-Ethnic Study of Atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology 20110601
Kinesin-like protein 6 (KIF6) polymorphism and the efficacy of rosuvastatin in primary prevention.	Circulation. Cardiovascular genetics 20110601
Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study.	International journal of clinical practice 20110601
The effects of atorvastatin and rosuvastatin on oxidative stress in diabetic patients.	European journal of internal medicine 20110601
High-sensitivity C-reactive protein, obesity, and subclinical atherosclerosis: implications of JUPITER from the MESA study.	Arteriosclerosis, thrombosis, and vascular biology 20110601
Effect of rosuvastatin on C-reactive protein and progression of aortic stenosis.	American heart journal 20110601
Longitudinal assessment of estimated glomerular filtration rate in apparently healthy adults: a post hoc analysis from the JUPITER study (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).	Clinical therapeutics 20110601
[Effect of OATP1B1 521T --> C heterogenesis on pharmacokinetic characterstics of rosuvastatin in Chinese volunteers].	Yao xue xue bao = Acta pharmaceutica Sinica 20110601
Fish odour syndrome.	CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20110517
The editor's roundtable: JUPITER follow-up.	The American journal of cardiology 20110515
Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C.	Journal of viral hepatitis 20110501
No effect of rosuvastatin in the zoledronate-induced acute-phase response.	Calcified tissue international 20110501
Statins alleviate experimental nerve injury-induced neuropathic pain.	Pain 20110501
Evaluating optimal lipid levels in patients with mixed dyslipidemia following short- and long-term treatment with fenofibric acid and statin combination therapy: a post hoc analysis.	Current medical research and opinion 20110501
Rosuvastatin prevents myocardial necrosis in an experimental model of acute myocardial infarction.	Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20110501
The methyl ester of rosuvastatin elicited an endothelium-independent and 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent relaxant effect in rat aorta.	Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20110501
Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin).	Journal of the American College of Cardiology 20110419
Low coenzyme Q₁₀ levels and the outcome of statin treatment in heart failure.	Journal of the American College of Cardiology 20110405
Improved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9.	Journal of lipid research 20110401
The role of C-reactive protein as a risk predictor of coronary atherosclerosis: implications from the JUPITER trial.	Current atherosclerosis reports 20110401
Different effects of rosuvastatin and simvastatin on myocardial high-energy phosphate metabolism.	International journal of cardiology 20110401
Statins should be used with greater caution in patients undergoing thyroid hormone withdrawal for radioactive iodine treatment.	Thyroid : official journal of the American Thyroid Association 20110401
Rosuvastatin and primary cardiovascular prevention. Continue to use pravastatin or simvastatin.	Prescrire international 20110401
Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis.	BMJ (Clinical research ed.) 20110330
Simultaneous determination of rosuvastatin and atorvastatin in human serum using RP-HPLC/UV detection: method development, validation and optimization of various experimental parameters.	Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110315
Rosuvastatin lowers coenzyme Q10 levels, but not mitochondrial adenosine triphosphate synthesis, in children with familial hypercholesterolemia.	The Journal of pediatrics 20110301
Rosuvastatin and thapsigargin modulate γ-secretase gene expression and APP processing in a human neuroglioma model.	Journal of molecular neuroscience : MN 20110301
Differential metabolic effects of distinct statins.	Atherosclerosis 20110301
Optimal statin type and dosage for vascular patients.	Journal of vascular surgery 20110301
Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.	Circulation. Heart failure 20110301
Genetics of the coenzyme Q10 pathway and rosuvastatin-induced muscle effects.	The Journal of pediatrics 20110301
Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificity.	Pharmacogenetics and genomics 20110301
Severe rhabdomyolysis due to rosuvastatin in a liver transplant subject with human immunodeficiency virus and immunosuppressive therapy-related dyslipidemia.	Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20110301
[Effects of rosuvastatin on monocrotaline-induced pulmonary artery hypertension in rats].	Zhonghua xin xue guan bing za zhi 20110301
Low-density lipoprotein cholesterol goal attainment among Malaysian dyslipidemic patients.	The Southeast Asian journal of tropical medicine and public health 20110301
The cost-effectiveness of C-reactive protein testing and rosuvastatin treatment for patients with normal cholesterol levels.	Journal of the American College of Cardiology 20110215
The cost-effectiveness of rosuvastatin therapy JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).	Journal of the American College of Cardiology 20110215
Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study.	International journal of cardiology 20110203
Insulin resistance due to statin therapy: a potential contributor to the negation of statin-induced beneficial effects on cardiac remodelling in heart failure?	International journal of cardiology 20110203
Outcomes of high dose statin loading therapy.	International journal of cardiology 20110203
Small leucine-rich proteoglycans in atherosclerotic lesions: novel targets of chronic statin treatment?	Journal of cellular and molecular medicine 20110201
Rosuvastatin induces apoptosis in CD4(+)CD28 (null) T cells in patients with acute coronary syndromes.	Clinical research in cardiology : official journal of the German Cardiac Society 20110201
Public health impact of statin prescribing strategies based on JUPITER.	Preventive medicine 20110201
Achievement of lipid targets with the combination of rosuvastatin and fenofibric Acid in patients with type 2 diabetes mellitus.	Cardiovascular drugs and therapy 20110201
Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients.	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20110201
A crossover study of rosuvastatin and pitavastatin in patients with type 2 diabetes.	Advances in therapy 20110201
Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation.	The American journal of cardiology 20110201
Alternate day rosuvastatin, an underutilized option in statin intolerant hyperlipidemic patients: a case report and literature review.	Tennessee medicine : journal of the Tennessee Medical Association 20110201
Long-term efficacy of adding fenofibric acid to moderate-dose statin therapy in patients with persistent elevated triglycerides.	Cardiovascular drugs and therapy 20110201
eNOS/Hsp70 interaction on rosuvastatin cytoprotective effect in neonatal obstructive nephropathy.	European journal of pharmacology 20110115
High-dose rosuvastatin in chronic heart failure promotes vasculogenesis, corrects endothelial function, and improves cardiac remodeling--results from a randomized, double-blind, and placebo-controlled study.	International journal of cardiology 20110107
12-month follow-up results of high dose rosuvastatin loading before percutaneous coronary intervention in patients with acute coronary syndrome.	International journal of cardiology 20110107
Unending debate: statin dilemma in the management of heart failure.	International journal of cardiology 20110107
Pre-procedural use of statins for all patients undergoing percutaneous coronary intervention.	International journal of cardiology 20110107
Rosuvastatin restored adrenergic and nitrergic function in mesenteric arteries from obese rats.	British journal of pharmacology 20110101
Differential effect of genetic variants of Na(+)-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors.	Xenobiotica; the fate of foreign compounds in biological systems 20110101
Involvement of the p38 pathway in the differential induction of heme oxygenase-1 by statins in Neuro-2A cells exposed to lipopolysaccharide.	Drug and chemical toxicology 20110101
Rosuvastatin for primary prevention in patients with European systematic coronary risk evaluation risk ≥ 5% or Framingham risk >20%: post hoc analyses of the JUPITER trial requested by European health authorities.	European heart journal 20110101
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia.	Atherosclerosis 20110101
Suppression of Idol expression is an additional mechanism underlying statin-induced up-regulation of hepatic LDL receptor expression.	International journal of molecular medicine 20110101
The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins.	Expert opinion on drug metabolism & toxicology 20110101
Aleglitazar, a balanced PPARα/γ agonist, has no clinically relevant pharmacokinetic interaction with high-dose atorvastatin or rosuvastatin.	Expert opinion on investigational drugs 20110101
Paradoxical decrease in HDL-cholesterol and apolipoprotein A1 with simvastatin and atorvastatin in a patient with type 2 diabetes.	Annals of clinical biochemistry 20110101
Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: the impact of inflammatory process and oxidative stress.	Atherosclerosis 20110101
The risks of a new hypothesis: why did JUPITER patients have almost twice the predicted event rate of reduction?	Journal of cardiovascular medicine (Hagerstown, Md.) 20110101
Race differences: modeling the pharmacodynamics of rosuvastatin in Western and Asian hypercholesterolemia patients.	Acta pharmacologica Sinica 20110101
Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis.	Circulation journal : official journal of the Japanese Circulation Society 20110101
Early intervention with rosuvastatin decreases the lipid components of the plaque in acute coronary syndrome: analysis using integrated backscatter IVUS (ELAN study).	Circulation journal : official journal of the Japanese Circulation Society 20110101
Evaluating the effectiveness of rosuvastatin in preventing the progression of diastolic dysfunction in aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study.	Cardiovascular ultrasound 20110101
A Canadian Critical Care Trials Group project in collaboration with the international forum for acute care trialists - Collaborative H1N1 Adjuvant Treatment pilot trial (CHAT): study protocol and design of a randomized controlled trial.	Trials 20110101
Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly.	Clinical interventions in aging 20110101
Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): the PATROL trial.	Circulation journal : official journal of the Japanese Circulation Society 20110101
Rosuvastatin treatment activates JAK-STAT pathway and increases efficacy of allogeneic mesenchymal stem cell transplantation in infarcted hearts.	Circulation journal : official journal of the Japanese Circulation Society 20110101
[Possible rosuvastatin-induced fatal rhabdomyolysis].	Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20110101
Strong statins as the major players for dyslipidemia in high-risk patients: are they all the same or not?	Circulation journal : official journal of the Japanese Circulation Society 20110101
Rhabdomyolysis in an HIV-infected patient with impaired renal function concomitantly treated with rosuvastatin and lopinavir/ritonavir.	Antiviral therapy 20110101
Primary prevention with statins is more cost-effective.	Cardiovascular journal of Africa 20110101
Clinical use and effectiveness of lipid lowering therapies in diabetes mellitus--an observational study from the Swedish National Diabetes Register.	PloS one 20110101
The use of plaque score measurements to assess changes in atherosclerotic plaque burden induced by lipid-lowering therapy over time: the METEOR study.	Journal of atherosclerosis and thrombosis 20110101
Efficacy analysis of the lipid-lowering and renoprotective effects of rosuvastatin in patients with chronic kidney disease.	Endocrine journal 20110101
Rosuvastatin therapy does not affect serum MMP-13 or TIMP-1 levels in hypercholesterolemic patients.	Texas Heart Institute journal 20110101
Effect of atorvastatin vs. rosuvastatin on cardiac sympathetic nerve activity in non-diabetic patients with dilated cardiomyopathy.	Circulation journal : official journal of the Japanese Circulation Society 20110101
Efficacy and tolerability of once-weekly rosuvastatin in patients with previous statin intolerance.	Journal of clinical lipidology 20110101
Concordance between plasma apolipoprotein B levels and cholesterol indices among patients receiving statins and nonstatin treatment: Post-hoc analyses from the U.K. InPractice study.	Journal of clinical lipidology 20110101
Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.	Drug design, development and therapy 20110101
The role of soluble fiber intake in patients under highly effective lipid-lowering therapy.	Nutrition journal 20110101
Clinical usefulness of additional treatment with ezetimibe in patients with coronary artery disease on statin therapy. - From the viewpoint of cholesterol metabolism.-.	Circulation journal : official journal of the Japanese Circulation Society 20110101
Intensive lipid-lowering therapy with rosuvastatin stabilizes lipid-rich coronary plaques. -Evaluation using dual-source computed tomography.-.	Circulation journal : official journal of the Japanese Circulation Society 20110101
A systems biology strategy for predicting similarities and differences of drug effects: evidence for drug-specific modulation of inflammation in atherosclerosis.	BMC systems biology 20110101
Comparative efficacy of ezetimibe/simvastatin, rosuvastatin, and atorvastatin in uncontrolled hyperlipidemia patients.	The American journal of managed care 20110101
Low-dose rosuvastatin improves arterial stiffness in high-risk Japanese patients with dyslipdemia in a primary prevention group.	Circulation journal : official journal of the Japanese Circulation Society 20110101
No evidence for statin-induced proteinuria in healthy volunteers as assessed by proteomic analysis.	Journal of biomedicine & biotechnology 20110101
Effects of lipid-lowering therapy with rosuvastatin on kidney function and oxidative stress in patients with diabetic nephropathy.	Journal of atherosclerosis and thrombosis 20110101
Soybean glycinin improves HDL-C and suppresses the effects of rosuvastatin on hypercholesterolemic rats.	Lipids in health and disease 20110101
Estimating treatment effects for individual patients based on the results of randomised clinical trials.	BMJ (Clinical research ed.) 20110101
Effects of combination therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein (≥ 2 mg/L). cmb@bcm.tmc.edu.	Journal of clinical lipidology 20110101
Effect of rosuvastatin treatment on cholesterol efflux from human macrophages.	Neuro endocrinology letters 20110101
Extreme all-cause mortality in JUPITER requires reexamination of vital records.	Cardiology 20110101
Is chronic severe anemia an independent predictor of poor outcomes?	Cardiology 20110101
[Statins in primary prophylaxis of cardiovascular diseases].	Terapevticheskii arkhiv 20110101
Effects of rosuvastatin versus atorvastatin on rho-associated coiled-coil containing protein kinase activity and endothelial function in patients with atherosclerosis.	The Journal of international medical research 20110101
Statin resistant dyslipidemia in a patient treated with amiodarone.	BMJ case reports 20110101
Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agents.	International journal of cancer 20101215
Trials by independent expert bodies.	Archives of internal medicine 20101213
Letter by Wells and Eisenberg regarding article, 'Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials'.	Circulation 20101207
Letter by Vos et al regarding article, 'Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials'.	Circulation 20101207
Comparative effects of rosuvastatin and allopurinol on circulating levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with chronic heart failure.	International journal of cardiology 20101203
Rosuvastatin and vitamin D: might there be hypovitaminosis D on JUPITER?	International journal of cardiology 20101203
Immunomodulatory effects of rosuvastatin on hepatic ischemia/reperfusion induced injury.	Immunopharmacology and immunotoxicology 20101201
Adding exercise to rosuvastatin treatment: influence on C-reactive protein, monocyte toll-like receptor 4 expression, and inflammatory monocyte (CD14+CD16+) population.	Metabolism: clinical and experimental 20101201
Use of multiple international healthcare databases for the detection of rare drug-associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins.	Pharmacoepidemiology and drug safety 20101201
Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial.	European journal of heart failure 20101201
Efficacy and safety of rosuvastatin 5 mg in combination with fenofibric acid 135 mg in patients with mixed dyslipidemia - a phase 3 study.	Cardiovascular drugs and therapy 20101201
Effect of central obesity, low high-density lipoprotein cholesterol and C-reactive protein polymorphisms on C-reactive protein levels during treatment with Rosuvastatin (10 mg Daily).	The American journal of cardiology 20101201
Characteristics and drug utilization patterns of new users of rosuvastatin and other statins in four countries.	Minerva cardioangiologica 20101201
WT-1 mRNA expression is modulated by nitric oxide availability and Hsp70 interaction after neonatal unilateral ureteral obstruction.	Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al 20101201
HDL cholesterol and residual risk of first cardiovascular events.	Lancet (London, England) 20101120
Rosuvastatin reduces microglia in the brain of wild type and ApoE knockout mice on a high cholesterol diet; implications for prevention of stroke and AD.	Biochemical and biophysical research communications 20101112
No effect of rosuvastatin on left ventricular hypertrophy in patients with hypertension: a prospective randomised open-label study with blinded endpoint assessment.	International journal of cardiology 20101105
Comparison of rosuvastatin and atorvastatin on clopidogrel response and lipidic and inflammatory parameters after coronary stenting for acute coronary syndrome: the prospective, randomized OSCAR study (optimal statin therapy with clopidogrel after coronary revascularisation).	Thrombosis research 20101101
[On the current debate on lowering LDL cholesterol with ezetimibe].	Deutsche medizinische Wochenschrift (1946) 20101101
Impact of baseline plaque components on plaque progression in nonintervened coronary segments in patients with angina pectoris on rosuvastatin 10 mg/day.	The American journal of cardiology 20101101
The JUPITER Trial: responding to the critics.	The American journal of cardiology 20101101
Statin therapy in primary prevention: new insights regarding women and the elderly.	The American journal of cardiology 20101101
Endothelial progenitor cells in patients with acute cerebrovascular ischemia.	The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20101101
Prevalence of dyslipidemia in statin-treated patients in Canada: results of the DYSlipidemia International Study (DYSIS).	The Canadian journal of cardiology 20101101
Serum levels of C-reactive protein in patients with stable coronary artery disease: JUPITER in perspective.	International journal of cardiology 20101029
High-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosis.	Circulation 20101026
Is diabetes the cost to pay for a greater cardiovascular prevention?	International journal of cardiology 20101008
Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure).	Journal of the American College of Cardiology 20101005
Coenzyme Q10 and statins in heart failure: the dog that didn't bark.	Journal of the American College of Cardiology 20101005
Coadministration of dalcetrapib with pravastatin, rosuvastatin, or simvastatin: no clinically relevant drug-drug interactions.	Journal of clinical pharmacology 20101001
Upregulation of ecto-5'-nucleotidase by rosuvastatin increases the vasodilator response to ischemia.	Hypertension (Dallas, Tex. : 1979) 20101001
Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients.	Pharmacogenetics and genomics 20101001
Change in serum lipids after acute coronary syndromes: secondary analysis of SPACE ROCKET study data and a comparative literature review.	Clinical chemistry 20101001
Effect of increasing doses of Rosuvastatin and Atorvastatin on apolipoproteins, enzymes and lipid transfer proteins involved in lipoprotein metabolism and inflammatory parameters.	Current medical research and opinion 20101001
Lactone pathway to statins utilizing the Wittig reaction. The synthesis of rosuvastatin.	The Journal of organic chemistry 20101001
Rhabdomyolysis induced by rosuvastatin and sildenafil.	Southern medical journal 20101001
Cost-effectiveness of statin therapy for vascular event prevention in adults with elevated C-reactive protein: implications of JUPITER.	Current medical research and opinion 20101001
Case report. Hyperlipoproteinaemia(a): which is the optimal therapy? A case report.	Journal of clinical pharmacy and therapeutics 20101001
Ancestry as a determinant of mean population C-reactive protein values: implications for cardiovascular risk prediction.	Circulation. Cardiovascular genetics 20101001
Combination rosuvastatin plus fenofibric acid in a cohort of patients 65 years or older with mixed dyslipidemia: subanalysis of two randomized, controlled studies.	Clinical cardiology 20101001
Heterozygous familial hypercholesterolemia case study.	Journal of the American Academy of Nurse Practitioners 20101001
Effects of statins on vascular endothelial function in hypercholesterolemic patients with type 2 diabetes mellitus: fluvastatin vs. rosuvastatin.	International journal of cardiology 20100924
Interpreting and evaluating the details of the JUPITER study.	American family physician 20100915
Effect of a single gemfibrozil dose on the pharmacokinetics of rosuvastatin in bile and plasma in healthy volunteers.	Journal of clinical pharmacology 20100901
Rosuvastatin-induced gynaecomastia.	Clinical endocrinology 20100901
The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse.	American journal of physiology. Renal physiology 20100901
Rosuvastatin added to standard heart failure therapy improves cardiac remodelling in heart failure rats with preserved ejection fraction.	European journal of heart failure 20100901
Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer.	European urology 20100901
Impact of restricted reimbursement on the use of statins in Finland: a register-based study.	Medical care 20100901
Rosuvastatin for primary prevention among individuals with elevated high-sensitivity c-reactive protein and 5% to 10% and 10% to 20% 10-year risk. Implications of the Justification for Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial for 'intermediate risk'.	Circulation. Cardiovascular quality and outcomes 20100901
Relationship between bicuspid aortic valve morphology and aortic wall degeneration: further evidence is emerging.	Echocardiography (Mount Kisco, N.Y.) 20100901
Statin loading before percutaneous coronary intervention: proposed mechanisms and applications.	Future cardiology 20100901
[Rosuvastatin enhances the protective effects of ischemic postconditioning on myocardial ischaemia-reperfusion injury in type 2 diabetic rat].	Zhonghua xin xue guan bing za zhi 20100901
[Role of rosuvastatin in current lipid-lowering therapy].	Orvosi hetilap 20100829
C-reactive protein lowering with rosuvastatin in the METEOR study.	Journal of internal medicine 20100801
Antioxidant, antinociceptive and anti-inflammatory activities of atorvastatin and rosuvastatin in various experimental models.	Inflammopharmacology 20100801
The effect of acute administration of rifampicin and imatinib on the enterohepatic transport of rosuvastatin in vivo.	Xenobiotica; the fate of foreign compounds in biological systems 20100801
Improved cardiac performance by rosuvastatin is associated with attenuations in both myocardial tumor necrosis factor-alpha and p38 MAP kinase activity in rats after myocardial infarction.	The American journal of the medical sciences 20100801
Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial.	American heart journal 20100801
Statin therapy for elevated hsCRP: what are the public health implications?	The American journal of managed care 20100801
Statin therapy for elevated hsCRP: more evidence is needed.	The American journal of managed care 20100801
Was the FDA misled by JUPITER?	The Journal of the American Osteopathic Association 20100801
Cost-effectiveness of rosuvastatin for primary prevention of cardiovascular events according to Framingham Risk Score in patients with elevated C-reactive protein.	The Journal of the American Osteopathic Association 20100801
HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial.	Lancet (London, England) 20100731
Rosuvastatin preconditioning provides neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressions.	Brain research 20100730
Homozygous familial hypercholesterolaemia and treatment by LDL apheresis.	The New Zealand medical journal 20100730
Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER).	The American journal of cardiology 20100715
Rosuvastatin stimulates clonogenic potential and anti-inflammatory properties of endothelial progenitor cells.	Cell biology international 20100701
Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, increases survival in stroke-prone rats by preventing systemic inflammation and endothelial dysfunction: comparison with aspirin and rosuvastatin.	The Journal of pharmacology and experimental therapeutics 20100701
Expression of the hepatic Niemann-Pick C1 like 1 protein gene is sensitive to rosuvastatin treatment of primary human hepatocytes.	Pharmacogenetics and genomics 20100701
Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets.	International journal of clinical practice 20100701
Imperfect pharmacovigilance.	Southern medical journal 20100701
Rosuvastatin-induced thrombocytopenia.	Southern medical journal 20100701
Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?	Pharmacogenomics 20100701
Cholesterol lowering, cardiovascular diseases, and the rosuvastatin-JUPITER controversy: a critical reappraisal.	Archives of internal medicine 20100628
Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering.	International journal of cardiology 20100625
JUPITER, rosuvastatin, and the European Medicines Agency.	Lancet (London, England) 20100612
Rosuvastatin protects tissue perfusion in the experimental testicular torsion model.	International urology and nephrology 20100601
Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters.	Journal of lipid research 20100601
Effects of atorvastatin 20 mg, rosuvastatin 10 mg, and atorvastatin/ezetimibe 5 mg/5 mg on lipoproteins and glucose metabolism.	Journal of cardiovascular pharmacology and therapeutics 20100601
Hepatic metabolism and transporter gene variants enhance response to rosuvastatin in patients with acute myocardial infarction: the GEOSTAT-1 Study.	Circulation. Cardiovascular genetics 20100601
Glucose-regulated protein 78 and platelet deposition: effect of rosuvastatin.	Arteriosclerosis, thrombosis, and vascular biology 20100601
Acute renal failure with the combined use of rosuvastatin and fenofibrate.	Renal failure 20100601
Effects of three strong statins (atorvastatin, pitavastatin, and rosuvastatin) on serum uric acid levels in dyslipidemic patients.	Nucleosides, nucleotides & nucleic acids 20100601
[The AURORA study].	Giornale italiano di cardiologia (2006) 20100601
Highly stereoselective hydrogenations--as key-steps in the total synthesis of statins.	Chirality 20100515
Effects of rosuvastatin on myeloperoxidase levels in patients with chronic heart failure: a randomized placebo-controlled study.	Atherosclerosis 20100501
Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes.	Atherosclerosis 20100501
ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatin.	Clinical pharmacology and therapeutics 20100501
Reversal of age-associated memory impairment by rosuvastatin in rats.	Experimental gerontology 20100501
Cost-effectiveness of rosuvastatin versus ezetimibe/simvastatin in managing dyslipidemic patients in Mexico.	Current medical research and opinion 20100501
By the way, doctor. I take a fiber supplement, but have heard that I shouldn't be taking it at the same times as medication. How far apart should I take fiber and medicines such as Plavix and Crestor?	Harvard health letter 20100501
Can intensive lipid-lowering therapy with statins ameliorate atherosclerosis in Japanese patients? Rationale and design of the JART study.	Journal of atherosclerosis and thrombosis 20100430
Summaries for patients. Rosuvastatin to prevent heart problems and stroke in persons 70 years or older.	Annals of internal medicine 20100420
Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial.	Annals of internal medicine 20100420
Statins for primary prevention in older adults: who is high risk, who is old, and what denotes primary prevention?	Annals of internal medicine 20100420
Rosuvastatin and cardiovascular continuum when time is important.	Journal of the American College of Cardiology 20100413
FDA approves a statin therapy for some: certain, asymptomatic individuals targeted.	JAMA 20100407
In vivo performance of absorbable collagen sponges with rosuvastatin in critical-size cortical bone defects.	Acta biomaterialia 20100401
Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study.	European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 20100401
Use of a combination of prednisolone and rosuvastatin for treatment of a pyogranuloma in a dog.	Journal of the American Veterinary Medical Association 20100401
Should we measure C-reactive protein on earth or just on JUPITER?	Clinical cardiology 20100401
Enhanced effect of losartan and rosuvastatin on neointima hyperplasia.	Archives of pharmacal research 20100401
Achieving treatment goals in low-risk, asymptomatic patients.	The Journal of the American Osteopathic Association 20100401
New analysis supports expanded use of statins in women.	Harvard women's health watch 20100401
Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial.	Journal of the American College of Cardiology 20100323
Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia.	Journal of the American College of Cardiology 20100316
Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials.	Circulation 20100309
The numbers are in: statins for the primary prevention of cardiovascular disease in women.	Circulation 20100309
Rosuvastatin prevents conduit artery endothelial dysfunction induced by ischemia and reperfusion by a cyclooxygenase-2-dependent mechanism.	Journal of the American College of Cardiology 20100309
Biliary efflux transporters involved in the clearance of rosuvastatin in sandwich culture of primary rat hepatocytes.	Toxicology in vitro : an international journal published in association with BIBRA 20100301
Comparison of sequential rosuvastatin doses in hypercholesterolaemia: a meta-analysis of randomised controlled trials.	Current medical research and opinion 20100301
Signal detection of rosuvastatin compared to other statins: data-mining study using national health insurance claims database.	Pharmacoepidemiology and drug safety 20100301
Persistent regional diastolic dysfunction after myocardial ischemia and the effect of statin treatment: assessment with two-dimensional radial strain rate.	Echocardiography (Mount Kisco, N.Y.) 20100301
Comparative study of low doses of rosuvastatin and atorvastatin on lipid and glycemic control in patients with metabolic syndrome and hypercholesterolemia.	The Korean journal of internal medicine 20100301
Interpreting the JUPITER trial: statins can prevent VTE, but more study is needed.	Cleveland Clinic journal of medicine 20100301
The effects of rosuvastatin on the serum cortisol, serum lipid, and serum mevalonic acid levels in the healthy Indian male population.	AAPS PharmSciTech 20100301
[Effects of rosuvastatin on left ventricular cardiac function, arteriosclerotic plaque and high sensitive C-reactive protein in hypertensive patients with mild LDL-C elevation].	Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20100301
Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study.	Clinical therapeutics 20100301
Pharmacokinetics of rosuvastatin in healthy Chinese volunteers living in China: a randomized, open-label, ascending single- and multiple-dose study.	Clinical therapeutics 20100301
Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: results of the CENTAURUS study.	Archives of cardiovascular diseases 20100301
Effects of rosuvastatin on coronary flow reserve and metabolic mismatch in patients with heart failure (from the CORONA Study).	The American journal of cardiology 20100215
Rosuvastatin inhibits norepinephrine-induced cardiac hypertrophy via suppression of Gh.	European journal of pharmacology 20100210
Human skeletal muscle drug transporters determine local exposure and toxicity of statins.	Circulation research 20100205
Association of Bicuspid aortic valve morphology and aortic root dimensions: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study.	Echocardiography (Mount Kisco, N.Y.) 20100201
Prescribing statins in aortic stenosis: little to lose, much to gain.	European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20100201
Ammonium methacrylate units polymer content and their effect on acyclovir colloidal nanoparticles properties and bioavailability in human volunteers.	Colloids and surfaces. B, Biointerfaces 20100201
The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy.	The pharmacogenomics journal 20100201
Rosuvastatin induces delayed preconditioning against L-glutamate excitotoxicity in cultured cortical neurons.	Neurochemistry international 20100201
Measuring hsCRP--an important part of a comprehensive risk profile or a clinically redundant practice?	PLoS medicine 20100201
Prevention of peri-procedural myocardial injury using a single high loading dose of rosuvastatin.	Cardiovascular drugs and therapy 20100201
Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial.	Circulation 20100119
Public health. U.S. panel favors wider use of preventive drug treatment.	Science (New York, N.Y.) 20100108
Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER).	Circulation 20100105
Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial.	AIDS (London, England) 20100102
Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier.	Drug metabolism and disposition: the biological fate of chemicals 20100101
Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis.	Diabetes research and clinical practice 20100101
Year two assessment of fenofibric acid and moderate-dose statin combination: a phase 3, open-label, extension study.	Clinical drug investigation 20100101
An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial.	European journal of heart failure 20100101
Earth to JUPITER: how a potent statin may actually be detrimental for lifestyle-associated diseases.	Angiology 20100101
HMG-CoA reductase inhibitor improves endothelial dysfunction in spontaneous hypertensive rats via down-regulation of caveolin-1 and activation of endothelial nitric oxide synthase.	Journal of Korean medical science 20100101
Meta-analysis of comparative efficacy of increasing dose of Atorvastatin versus Rosuvastatin versus Simvastatin on lowering levels of atherogenic lipids (from VOYAGER).	The American journal of cardiology 20100101
Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia.	American journal of cardiovascular drugs : drugs, devices, and other interventions 20100101
One-year treatment with rosuvastatin reduces intima-media thickness in 45 hypercholesterolemic subjects with asymptomatic carotid artery disease.	Pharmacology 20100101
Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.	American journal of cardiovascular drugs : drugs, devices, and other interventions 20100101
Effect of rosuvastatin on cholestasis-induced hepatic injury in rat livers.	Journal of biochemical and molecular toxicology 20100101
[Non-ST-elevation acute coronary syndrome. Comparison of effects of atorvastatin and rosuvastatin on blood levels of lipids and markers of inflammation].	Kardiologiia 20100101
Efficacy and safety of ezetimibe for Japanese patients with dyslipidaemia: The ESSENTIAL Study.	Clinical drug investigation 20100101
Cardiovascular risk in uremic patients: darkness after AURORA.	Renal failure 20100101
Is Jupiter also a god of primary prevention?	Texas Heart Institute journal 20100101
The Post-JUPITER trial era and the cost of preventive medicine.	Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 20100101
From CARDS to AURORA: one disease, two responses.	Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 20100101
Pharmacokinetic/pharmacodynamic modeling and simulation of rosuvastatin using an extension of the indirect response model by incorporating a circadian rhythm.	Biological & pharmaceutical bulletin 20100101
Efficacy and safety of rosuvastatin and fenofibric acid combination therapy versus simvastatin monotherapy in patients with hypercholesterolemia and hypertriglyceridemia: a randomized, double-blind study.	American journal of cardiovascular drugs : drugs, devices, and other interventions 20100101
Cost effectiveness of rosuvastatin in patients at risk of cardiovascular disease based on findings from the JUPITER trial.	Journal of medical economics 20100101
The endothelial-protective effects of HMG-CoA reductase inhibition in the setting of ischemia and reperfusion injury.	Clinical hemorheology and microcirculation 20100101
Determination of rosuvastatin and ezetimibe in a combined tablet dosage form using high-performance column liquid chromatography and high-performance thin-layer chromatography.	Journal of AOAC International 20100101
Ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency.	Lipids in health and disease 20100101
Rosuvastatin promotes osteoblast differentiation and regulates SLCO1A1 transporter gene expression in MC3T3-E1 cells.	Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20100101
Rosuvastatin: a review of its use in the prevention of cardiovascular disease in apparently healthy women or men with normal LDL-C levels and elevated hsCRP levels.	American journal of cardiovascular drugs : drugs, devices, and other interventions 20100101
A case report of a diabetic woman with very low HDL cholesterol.	Journal of clinical lipidology 20100101
Complete Apo AI deficiency in an Iraqi Mandaean family: case studies and review of the literature.	Journal of clinical lipidology 20100101
Switching from high-efficacy lipid-lowering therapies to simvastatin and low-density lipoprotein cholesterol goal attainment in coronary heart disease/coronary heart disease-equivalent patients.	Journal of clinical lipidology 20100101
Rosuvastatin reduces neointima formation in a rat model of balloon injury.	European journal of medical research 20100101
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective.	Drug design, development and therapy 20100101

The Antimicrobial Agent Fusidic Acid Inhibits Organic Anion Transporting Polypeptide-Mediated Hepatic Clearance and May Potentiate Statin-Induced Myopathy.

Drug metabolism and disposition: the biological fate of chemicals 20160501

Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice.

PloS one 20160101

Optimized Hepatocyte-Like Cells with Functional Drug Transporters Directly-Reprogrammed from Mouse Fibroblasts and their Potential in Drug Disposition and Toxicology.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20160101

Transmembrane transport of steviol glucuronide and its potential interaction with selected drugs and natural compounds.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20151201

Clinical drug interaction profile of idelalisib in healthy subjects.

Journal of clinical pharmacology 20150801

Statins alter the hepatobiliary transport of unconjugated and conjugated bilirubin in sandwich-cultured rat hepatocytes.

Toxicology in vitro : an international journal published in association with BIBRA 20140901

Quercetin-3-rhamnoglucoside (rutin) stimulates transport of organic anion compounds mediated by organic anion transporting polypeptide 2B1.

Biopharmaceutics & drug disposition 20140401

Detection of statin cytotoxicity is increased in cells expressing the OATP1B1 transporter.

Toxicological sciences : an official journal of the Society of Toxicology 20130701

ATP-dependent transport of statins by human and rat MRP2/Mrp2.

Toxicology and applied pharmacology 20130601

Disposition of atorvastatin, rosuvastatin, and simvastatin in oatp1b2-/- mice and intraindividual variability in human subjects.

Journal of clinical pharmacology 20121101

Intronic variants in SLCO1B1 related to statin-induced myopathy are associated with the low-density lipoprotein cholesterol response to statins in Chinese patients with hyperlipidaemia.

Pharmacogenetics and genomics 20121101

Rosuvastatin improves vascular function of arteriovenous fistula in a diabetic rat model.

Journal of vascular surgery 20121101

The role of a basolateral transporter in rosuvastatin transport and its interplay with apical breast cancer resistance protein in polarized cell monolayer systems.

Drug metabolism and disposition: the biological fate of chemicals 20121101

Interaction between SNPs in the RXRA and near ANGPTL3 gene region inhibits apoB reduction after statin-fenofibric acid therapy in individuals with mixed dyslipidemia.

Journal of lipid research 20121101

Total cholesterol content of erythrocyte membranes is associated with the severity of coronary artery disease and the therapeutic effect of rosuvastatin.

Upsala journal of medical sciences 20121101

Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: a possible compensatory mechanism.

Nutrition, metabolism, and cardiovascular diseases : NMCD 20121001

Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease.

Cardiovascular therapeutics 20121001

Effect of statins on coronary bifurcation atherosclerosis: an intravascular ultrasound virtual histology study.

The international journal of cardiovascular imaging 20121001

Single-dose, 2-way crossover, bioequivalence study of two rosuvastatin formulations in normal healthy subjects under fasting conditions.

International journal of clinical pharmacology and therapeutics 20121001

Differences in synthesis and absorption of cholesterol of two effective lipid-lowering therapies.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20121001

Effect of rosuvastatin on the echolucency of the common carotid intima-media in low-risk individuals: the METEOR trial.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 20121001

Long-term effects of ezetimibe-plus-statin therapy on low-density lipoprotein cholesterol levels as compared with double-dose statin therapy in patients with coronary artery disease.

Atherosclerosis 20121001

Rosuvastatin may modulate insulin signaling and inhibit atherogenesis beyond its plasma cholesterol-lowering effect in insulin-resistant mice.

Cardiovascular drugs and therapy 20121001

Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: role of iNOS and VEGF.

European journal of pharmacology 20120915

Effects of rosuvastatin versus pravastatin on low-density lipoprotein diameter in HIV-1-infected patients receiving ritonavir-boosted protease inhibitor.

AIDS (London, England) 20120910

The therapeutic effect of rosuvastatin on cardiac remodelling from hypertrophy to fibrosis during the end-stage hypertension in rats.

Journal of cellular and molecular medicine 20120901

Use of uptake intrinsic clearance from attached rat hepatocytes to predict hepatic clearance for poorly permeable compounds.

Xenobiotica; the fate of foreign compounds in biological systems 20120901

Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study.

European heart journal 20120901

Use of mechanistic modeling to assess interindividual variability and interspecies differences in active uptake in human and rat hepatocytes.

Drug metabolism and disposition: the biological fate of chemicals 20120901

Comparison of the effects of different statins and doses on lipid levels in patients with diabetes: results from VOYAGER.

Nutrition, metabolism, and cardiovascular diseases : NMCD 20120901

Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression.

Oncology reports 20120901

Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.

European journal of heart failure 20120901

Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome.

International journal of clinical practice 20120901

Chronic exposure to environmental contaminant nonylphenol exacerbates adenine-induced chronic renal insufficiency: role of signaling pathways and therapeutic impact of rosuvastatin.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20120815

Caveolin-1-eNOS/Hsp70 interactions mediate rosuvastatin antifibrotic effects in neonatal obstructive nephropathy.

Nitric oxide : biology and chemistry 20120815

Balancing the cardiometabolic benefits and risks of statins.

Lancet (London, England) 20120811

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial.

Lancet (London, England) 20120811

Drug interaction profile for GSK2248761, a next generation non-nucleoside reverse transcriptase inhibitor.

British journal of clinical pharmacology 20120801

Rosuvastatin suppresses the liver microsomal CYP2C11 and CYP2C6 expression in male Wistar rats.

Xenobiotica; the fate of foreign compounds in biological systems 20120801

MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression.

Clinical science (London, England : 1979) 20120801

Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level.

Metabolism: clinical and experimental 20120801

Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet.

Clinical science (London, England : 1979) 20120801

Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.

Journal of cardiovascular pharmacology 20120801

CD11b+ bone marrow-derived monocytes are the major leukocyte subset responsible for retinal capillary leukostasis in experimental diabetes in mouse and express high levels of CCR5 in the circulation.

The American journal of pathology 20120801

Predictive value of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio for the prevention of stroke recurrence in Japanese patients treated with rosuvastatin.

Clinical drug investigation 20120801

Effects of statin treatments and polymorphisms in UGT1A1 and SLCO1B1 on serum bilirubin levels in Chinese patients with hypercholesterolaemia.

Atherosclerosis 20120801

Effect of intensive lipid-lowering treatment compared to moderate lipid-lowering treatment with rosuvastatin on endothelial function in high risk patients.

International journal of cardiology 20120726

Rosuvastatin combined with ramipril significantly reduced atheroma volume by anti-inflammatory mechanism: comparative analysis with rosuvastatin alone by intravascular ultrasound.

International journal of cardiology 20120712

Cardioprotective effects of rosuvastatin and carvedilol on delayed cardiotoxicity of doxorubicin in rats.

Toxicology mechanisms and methods 20120701

Rosuvastatin improves pulse wave reflection by restoring endothelial function.

Microvascular research 20120701

The farnesoid X receptor -1G>T polymorphism influences the lipid response to rosuvastatin.

Journal of lipid research 20120701

Simultaneous and spontaneous bilateral quadriceps tendons rupture.

American journal of physical medicine & rehabilitation 20120701

Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy.

Atherosclerosis 20120701

Non-every day statin administration--a literature review.

European journal of internal medicine 20120701

Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.

Pharmacotherapy 20120701

Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in female patients with non-ST-segment elevation acute coronary syndrome.

Chinese medical journal 20120701

Rosuvastatin slows the development of diastolic dysfunction in calcific aortic stenosis.

The Journal of heart valve disease 20120701

Pharmacokinetic interactions between clopidogrel and rosuvastatin: effects on vascular protection in subjects with coronary heart disease.

International journal of cardiology 20120628

The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3).

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20120620

Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial).

The American journal of cardiology 20120615

Change in near-infrared spectroscopy of a coronary artery after 1-year treatment with high dose rosuvastatin.

International journal of cardiology 20120614

[Effects of domestic rosuvastatin on coronary plaque in patients with mild-to-moderate coronary artery stenosis as evaluated by virtual histology-intravascular ultrasound].

Zhonghua yi xue za zhi 20120612

[Effectiveness of generic rosuvastatin in patients with ischaemic cerebrovascular disease].

Orvosi hetilap 20120603

Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy?

European journal of preventive cardiology 20120601

Steady-state pharmacokinetic interactions of darunavir/ritonavir with lipid-lowering agent rosuvastatin.

Journal of clinical pharmacology 20120601

Multiple imputation of missing repeated outcome measurements did not add to linear mixed-effects models.

Journal of clinical epidemiology 20120601

Biologically implausible carotid intima-media thickness measurement values: effects on rate of change over time.

Current medical research and opinion 20120601

A review of time courses and predictors of lipid changes with fenofibric acid-statin combination.

Cardiovascular drugs and therapy 20120601

Rosuvastatin effect on intima media thickness in adult vs elderly patients.

Frontiers in bioscience (Elite edition) 20120601

Severe hypertriglyceridaemia. Treatment with plasmapheresis.

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20120514

Expression of let-7i is associated with Toll-like receptor 4 signal in coronary artery disease: effect of statins on let-7i and Toll-like receptor 4 signal.

Immunobiology 20120501

[Extrapolating the NNT jeopardises biostatistics and leads to immortality].

Atencion primaria 20120501

Effects of rosuvastatin and atorvastatin on glycaemic control in Type 2 diabetes---the CORALL study.

Diabetic medicine : a journal of the British Diabetic Association 20120501

The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*.

Journal of internal medicine 20120501

Statins improve outcome in murine models of intracranial hemorrhage and traumatic brain injury: a translational approach.

Journal of neurotrauma 20120501

Comparison of lipid-modifying efficacy of rosuvastatin versus atorvastatin in patients with acute coronary syndrome (from the LUNAR study).

The American journal of cardiology 20120501

Relationship of lipoprotein-associated phospholipase A₂ mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: an analysis from the JUPITER trial.

Clinical chemistry 20120501

Sample size requirements in trials using repeated measurements and the impact of trial design.

Current medical research and opinion 20120501

Statins and glycaemic control--a cause for concern?

Diabetic medicine : a journal of the British Diabetic Association 20120501

Rosuvastatin might have an effect on C-reactive protein but not on rheumatoid disease activity: Tayside randomized controlled study.

Scottish medical journal 20120501

On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).

Journal of the American College of Cardiology 20120424

The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20120417

Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared to rosuvastatin 10 mg in high-risk patients with and without type 2 diabetes mellitus inadequately controlled despite prior statin monotherapy.

Cardiovascular therapeutics 20120401

Metabolic stress-induced inflammation plays a major role in the development of osteoarthritis in mice.

Arthritis and rheumatism 20120401

Understanding the interplay of drug transporters involved in the disposition of rosuvastatin in the isolated perfused rat liver using a physiologically-based pharmacokinetic model.

Xenobiotica; the fate of foreign compounds in biological systems 20120401

Effects of rosuvastatin on serum asymmetric dimethylarginine levels and atrial structural remodeling in atrial fibrillation dogs.

Pacing and clinical electrophysiology : PACE 20120401

One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response.

American journal of cardiovascular drugs : drugs, devices, and other interventions 20120401

Renal safety of intensive cholesterol-lowering treatment with rosuvastatin: a retrospective analysis of renal adverse events among 40,600 participants in the rosuvastatin clinical development program.

Atherosclerosis 20120401

Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.

Circulation. Cardiovascular genetics 20120401

Effects of HMG-CoA reductase inhibitor on experimental autoimmune myocarditis.

Cardiovascular drugs and therapy 20120401

Targeting HDL-cholesterol to reduce residual cardiovascular risk.

Current opinion in lipidology 20120401

Reversible dysphasia and statins.

Journal of Korean medical science 20120401

Rosuvastatin attenuates mucus secretion in a murine model of chronic asthma by inhibiting the gamma-aminobutyric acid type A receptor.

Chinese medical journal 20120401

Atorvastatin, not rosuvastatin, improves cardiac function in heart failure: a meta-analysis of randomized trials.

International journal of cardiology 20120308

Manual or semi-automated edge detection of the maximal far wall common carotid intima-media thickness: a direct comparison.

Journal of internal medicine 20120301

The effects of rosuvastatin and the CYP51A1 inhibitor LEK-935 on the proteome of primary human hepatocytes.

Drug metabolism and disposition: the biological fate of chemicals 20120301

Rosuvastatin elicits KDR-dependent vasculogenic response of human placental stem cells through PI3K/AKT pathway.

Pharmacological research 20120301

Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study.

Current medical research and opinion 20120301

Non-lipid effects of rosuvastatin-fenofibrate combination therapy in high-risk Asian patients with mixed hyperlipidemia.

Atherosclerosis 20120301

Therapeutic options for statin-intolerant patients.

Current medical research and opinion 20120301

The work-up for mixed hyperlipidemia: a case study.

The Journal of family practice 20120301

Effect of rosuvastatin on obesity-induced cardiac oxidative stress in Wistar rats--a preliminary study.

Indian journal of experimental biology 20120301

The importance of green chemistry in process research and development.

Chemical Society reviews 20120221

Proprotein convertase substilisin/kexin type 9 antagonism reduces low-density lipoprotein cholesterol in statin-treated hypercholesterolemic nonhuman primates.

The Journal of pharmacology and experimental therapeutics 20120201

Differential modulation of cytochrome P450 activity and the effect of 1-aminobenzotriazole on hepatic transport in sandwich-cultured human hepatocytes.

Drug metabolism and disposition: the biological fate of chemicals 20120201

Rosuvastatin blocks hERG current and prolongs cardiac repolarization.

Journal of pharmaceutical sciences 20120201

Efficacy and safety of coadministration of rosuvastatin, ezetimibe, and colestimide in heterozygous familial hypercholesterolemia.

The American journal of cardiology 20120201

Effect of pitavastatin vs. rosuvastatin on international normalized ratio in healthy volunteers on steady-state warfarin.

Current medical research and opinion 20120201

High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial.

European heart journal 20120201

Pharmacogenetic determinants of statin-induced reductions in C-reactive protein.

Circulation. Cardiovascular genetics 20120201

[HDL level or HDL function as the primary target in preventive cardiology].

Herz 20120201

My patient has an elevated hs-CRP. What does this mean? What should I do now?

JPMA. The Journal of the Pakistan Medical Association 20120201

Impact of 10 mg rosuvastatin daily or alternate-day on lipid profile and inflammatory markers.

Clinica chimica acta; international journal of clinical chemistry 20120118

A meta-analysis of randomized head-to-head trials of atorvastatin versus rosuvastatin for reductions in C-reactive protein.

International journal of cardiology 20120112

Enhancement of antioxidant defense mechanism by pitavastatin and rosuvastatin on obesity-induced oxidative stress in Wistar rats.

Toxicology mechanisms and methods 20120101

Short-term statin treatment does not prevent ischemia and reperfusion-induced endothelial dysfunction in humans.

Journal of cardiovascular pharmacology 20120101

Extensive or restricted ultrasound protocols to measure carotid intima-media thickness: analysis of completeness rates and impact on observed rates of change over time.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 20120101

Loss of the preconditioning effect of rosuvastatin during sustained therapy: a human in vivo study.

American journal of physiology. Heart and circulatory physiology 20120101

Cost-effectiveness of rosuvastatin 20 mg for the prevention of cardiovascular morbidity and mortality: a Swedish economic evaluation of the JUPITER trial.

Journal of medical economics 20120101

Rosuvastatin, proprotein convertase subtilisin/kexin type 9 concentrations, and LDL cholesterol response: the JUPITER trial.

Clinical chemistry 20120101

Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: Justification for Atherosclerosis Regression Treatment (JART) study.

Circulation journal : official journal of the Japanese Circulation Society 20120101

Intensive lipid-lowering therapy with statins for primary prevention.

Circulation journal : official journal of the Japanese Circulation Society 20120101

A simple assay for the simultaneous determination of rosuvastatin acid, rosuvastatin-5S-lactone, and N-desmethyl rosuvastatin in human plasma using liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Analytical and bioanalytical chemistry 20120101

Statins, plasma proprotein convertase subtilisin/kexin type 9 concentrations, and LDL lowering.

Clinical chemistry 20120101

Measuring carotid artery intima-media thickness: simplicity versus complexity?

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 20120101

Rosuvastatin preserves renal structure following unilateral ureteric obstruction in the neonatal rat.

American journal of nephrology 20120101

β-conglycinin combined with fenofibrate or rosuvastatin have exerted distinct hypocholesterolemic effects in rats.

Lipids in health and disease 20120101

Rhabdomyolysis and acute renal failure following hard physical activity in a patient treated with rosuvastatin.

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20120101

[Almanac 2011: Valvular heart disease. Review of select studies that have driven recent advances in clinical cardiology: in the care of the Editors' Network Task Force of the European Society of Cardiology].

Giornale italiano di cardiologia (2006) 20120101

The relation between serum lipids and lutein and zeaxanthin in the serum and retina: results from cross-sectional, case-control and case study designs.

Lipids in health and disease 20120101

Effects of rosuvastatin and atorvastatin on renal function: meta-analysis.

Circulation journal : official journal of the Japanese Circulation Society 20120101

Effects of some anti-diabetic and cardioprotective agents on proliferation and apoptosis of human coronary artery endothelial cells.

Cardiovascular diabetology 20120101

Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs.

PloS one 20120101

The effect of rosuvastatin in a murine model of influenza A infection.

PloS one 20120101

Rosuvastatin and the JUPITER trial: critical appraisal of a lifeless planet in the galaxy of primary prevention.

International journal of occupational and environmental health 20120101

Antibacterial activity of statins: a comparative study of atorvastatin, simvastatin, and rosuvastatin.

Annals of clinical microbiology and antimicrobials 20120101

Use of once-weekly statin in combination with ezetimibe in a patient with mitochondrial disease.

BMJ case reports 20120101

Rosuvastatin-induced pemphigoid.

BMJ case reports 20120101

Effect of rosuvastatin on ROCK activity, endothelial function, and inflammation in Asian patients with atherosclerosis.

Internal medicine (Tokyo, Japan) 20120101

LDL-induced impairment of human vascular smooth muscle cells repair function is reversed by HMG-CoA reductase inhibition.

PloS one 20120101

Adverse drug reaction: rosuvastatin as a cause for ischaemic colitis in a 64-year-old woman.

BMJ case reports 20120101

[The Saturn study].

Giornale italiano di cardiologia (2006) 20120101

Combination treatment of rosuvastatin or atorvastatin, with regular exercise improves arterial wall stiffness in patients with coronary artery disease.

PloS one 20120101

The high-dose rosuvastatin once weekly study (the HD-ROWS).

Journal of clinical lipidology 20120101

[Atorvastatin or rosuvastatin? Select from the perspective of evidence-based medicine].

Kardiologiia 20120101

A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class.

PloS one 20120101

[Case of purpura nephritis accompanied by idiopathic cholesterol embolism].

Nihon Jinzo Gakkai shi 20120101

[How to prolong life of patients at high cardiovascular risk. Features of rosuvastatin].

Kardiologiia 20120101

Comparative effects of high and low-dose simvastatin on prostate epithelial cells: the role of LDL.

European journal of pharmacology 20111230

[Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): -- the PATROL trial].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20111210

[Symptomatic coronary heart disease. Impressive plaque reduction with high dose statins].

MMW Fortschritte der Medizin 20111208

Statins for primary prevention of venous thromboembolism.

The Cochrane database of systematic reviews 20111207

The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia.

Expert opinion on pharmacotherapy 20111201

The effect of herbal medicine danshensu and ursolic acid on pharmacokinetics of rosuvastatin in rats.

European journal of drug metabolism and pharmacokinetics 20111201

Effect of 2-year treatment with low-dose rosuvastatin on intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease.

Expert opinion on pharmacotherapy 20111201

Effect of two intensive statin regimens on progression of coronary disease.

The New England journal of medicine 20111201

[Effects of different statins, ezetimibe/simvastatin combination on hsCRP levels in unstable angina pectoris and non-ST elevation myocardial infarction patients: a randomized trial].

Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20111201

[Achievement of therapeutic target in subjects on statin treatment in clinical practice. Results of the STAR (Statins Target Assessment in Real practice) study].

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 20111201

Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.

JAMA 20111116

Simultaneous determination of timolol maleate, rosuvastatin calcium and diclofenac sodium in pharmaceuticals and physiological fluids using HPLC-UV.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20111115

Rosuvastatin does not affect human apolipoprotein A-I expression in genetically modified mice: a clue to the disputed effect of statins on HDL.

British journal of pharmacology 20111101

[Fibrillary nonamyloid glomerulonephritis: a rare etiology of nephrotic syndrome].

Nephrologie & therapeutique 20111101

Differential effect of statins on diabetic nephropathy in db/db mice.

International journal of molecular medicine 20111101

Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial.

Scandinavian journal of rheumatology 20111101

The human primary hepatocyte transcriptome reveals novel insights into atorvastatin and rosuvastatin action.

Pharmacogenetics and genomics 20111101

Algorithms to measure carotid intima-media thickness in trials: a comparison of reproducibility, rate of progression and treatment effect.

Journal of hypertension 20111101

Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance.

International journal of clinical practice 20111101

Drug safety evaluation of rosuvastatin.

Expert opinion on drug safety 20111101

Apolipoprotein B100 is a better treatment target than calculated LDL and non-HDL cholesterol in statin-treated patients.

Annals of clinical biochemistry 20111101

Clinical experience with rosuvastatin in the management of hyperlipidemia and the reduction of cardiovascular risk.

Expert review of cardiovascular therapy 20111101

[COSMOS (coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects) trial].

Nihon rinsho. Japanese journal of clinical medicine 20111101

Direct, metal-free amination of heterocyclic amides/ureas with NH-heterocycles and N-substituted anilines in POCl3.

The Journal of organic chemistry 20111021

Potential phototoxicity of rosuvastatin mediated by its dihydrophenanthrene-like photoproduct.

Chemical research in toxicology 20111017

Effect of rosuvastatin on hemoglobin levels in patients with anemia and low-grade inflammation: a post hoc analysis of the JUPITER trial.

Journal of clinical pharmacology 20111001

The JUPITER trial: myth or reality?

Current atherosclerosis reports 20111001

Lipid-altering efficacy of switching to ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk patients with and without metabolic syndrome.

Diabetes & vascular disease research 20111001

Renal toxicity of lisinopril and rosuvastatin, alone and in combination, in Wistar rats.

International journal of toxicology 20111001

Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation.

Journal of hypertension 20111001

[Rosuvastatin improves myocardial function and arteriosclerosis plaque in patients with ST-segment elevation after acute myocardial infarction and percutaneous coronary intervention].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20111001

I am a 60-year-old woman with CAD. My LDL is 64 and my HDL is 72 on Zocor, but my doctor thinks Crestor may be better for me. He says it is more potent and could reduce my numbers even more. I would have to pay for this drug out-of-pocket. Do you think the additional cost would be worth it?

Heart advisor 20111001

Rosuvastatin improves endothelial function in db/db mice: role of angiotensin II type 1 receptors and oxidative stress.

British journal of pharmacology 20110901

Cholesterol-independent neuroprotective and neurotoxic activities of statins: perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders.

Pharmacological research 20110901

Rosuvastatin attenuates monocrotaline-induced pulmonary hypertension via regulation of Akt/eNOS signaling and asymmetric dimethylarginine metabolism.

European journal of pharmacology 20110901

Culture period-dependent changes in the uptake of transporter substrates in sandwich-cultured rat and human hepatocytes.

Drug metabolism and disposition: the biological fate of chemicals 20110901

Rationale and design of STOP DVT study: rosuvastatin for the prevention of deep vein thrombosis in patients undergoing total knee replacement arthroplasty--a prospective randomized open-label controlled trial.

Contemporary clinical trials 20110901

Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study.

Lancet (London, England) 20110820

Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up-titration of rosuvastatin in patients with hypercholesterolemia (the ACTE Study).

The American journal of cardiology 20110815

Eltrombopag increases plasma rosuvastatin exposure in healthy volunteers.

British journal of clinical pharmacology 20110801

Statins prevent tissue factor induction by protease-activated receptors 1 and 2 in human umbilical vein endothelial cells in vitro.

Journal of thrombosis and haemostasis : JTH 20110801

Dose-dependent effect of rosuvastatin in the regulation of metalloproteinase expression.

Annals of vascular surgery 20110801

Radiation recall 5 years after whole-breast irradiation for early-stage breast cancer secondary to initiation of rosuvastatin and amlodipine.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110801

Rosuvastatin beneficially alters the glomerular structure of kidneys from spontaneously hypertensive rats (SHRs).

Journal of molecular histology 20110801

pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1.

Molecular pharmaceutics 20110801

Therapy and clinical trials: aggressive statin therapy versus combined and emerging approaches.

Current opinion in lipidology 20110801

HMG-CoA reductase inhibitors enhance phagocytosis by upregulating ATP-binding cassette transporter A7.

Atherosclerosis 20110801

Rosuvastatin blocks advanced glycation end products-elicited reduction of macrophage cholesterol efflux by suppressing NADPH oxidase activity via inhibition of geranylgeranylation of Rac-1.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20110801

A tale of three labels: translating the JUPITER trial data into regulatory claims.

Clinical trials (London, England) 20110801

A tale of five opinions (at least).

Clinical trials (London, England) 20110801

Regulatory divergence.

Clinical trials (London, England) 20110801

Translating study results to labeling.

Clinical trials (London, England) 20110801

Rosuvastatin prevents proteinuria and renal inflammation in nitric oxide-deficient rats.

Clinics (Sao Paulo, Brazil) 20110801

[Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].

Zhonghua xin xue guan bing za zhi 20110801

Anti-apoptotic potential of rosuvastatin pretreatment in murine model of cardiomyopathy.

International journal of cardiology 20110715

Effect of lipid-lowering treatment on natural history of heterozygous familial hypercholesterolemia in past three decades.

The American journal of cardiology 20110715

Determination of chamaechromone in rat plasma by liquid chromatography-tandem mass spectrometry: application to pharmacokinetic study.

Journal of pharmaceutical and biomedical analysis 20110715

Effects of rosuvastatin on progression of stenosis in adult patients with congenital aortic stenosis (PROCAS Trial).

The American journal of cardiology 20110715

Beneficial effects of rosuvastatin on aortic adverse remodeling in nitric oxide-deficient rats.

Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20110701

Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.

Drug metabolism and disposition: the biological fate of chemicals 20110701

Rosuvastatin combined with regular exercise preserves coenzyme Q10 levels associated with a significant increase in high-density lipoprotein cholesterol in patients with coronary artery disease.

Atherosclerosis 20110701

The statin class of HMG-CoA reductase inhibitors demonstrate differential activation of the nuclear receptors PXR, CAR and FXR, as well as their downstream target genes.

Xenobiotica; the fate of foreign compounds in biological systems 20110701

Rosuvastatin induces apoptosis in cultured human papillary thyroid cancer cells.

The Journal of endocrinology 20110701

Statins exert differential effects on angiotensin II-induced atherosclerosis, but no benefit for abdominal aortic aneurysms.

Atherosclerosis 20110701

Rosuvastatin attenuates the elevation in blood pressure induced by overexpression of human C-reactive protein.

Hypertension research : official journal of the Japanese Society of Hypertension 20110701

Rosuvastatin in diabetic hemodialysis patients.

Journal of the American Society of Nephrology : JASN 20110701

CRP induces hypertension in animal models: homo sapiens says no.

Hypertension research : official journal of the Japanese Society of Hypertension 20110701

Sunrise of statins after AURORA and 4D?

Journal of the American Society of Nephrology : JASN 20110701

Rosuvastatin, a new generation 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, reduces ischemia/reperfusion-induced spinal cord tissue injury in rats.

Annals of vascular surgery 20110701

Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.

American heart journal 20110701

[Pharmaco-economic optimization of cholesterol-lowering treatment with statins].

Medicina clinica 20110625

What else does the JUPITER trial add regarding C-reactive protein and cardiovascular disease?

International journal of cardiology 20110616

Impact of statins on glucose metabolism--a matter of debate.

The American journal of cardiology 20110615

Effects of pravastatin and rosuvastatin on the generation of adiponectin in the visceral adipose tissue in patients with coronary artery disease.

Fundamental & clinical pharmacology 20110601

Effects of rosuvastatin on vascular biomarkers and carotid atherosclerosis in lupus: a randomized, double-blind, placebo-controlled trial.

Arthritis care & research 20110601

High doses of rosuvastatin are superior to low doses of rosuvastatin plus fenofibrate or n-3 fatty acids in mixed dyslipidemia.

Lipids 20110601

Genetic polymorphisms in Na+-taurocholate co-transporting polypeptide (NTCP) and ileal apical sodium-dependent bile acid transporter (ASBT) and ethnic comparisons of functional variants of NTCP among Asian populations.

Xenobiotica; the fate of foreign compounds in biological systems 20110601

Switching from statin monotherapy to ezetimibe/simvastatin or rosuvastatin modifies the relationships between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients at high risk of coronary disease.

Clinical biochemistry 20110601

Combining rosuvastatin with sartans of different peroxisome proliferator-activated receptor-γ activating capacity is not associated with different changes in low-density lipoprotein subfractions and plasma lipoprotein-associated phospholipase A₂.

Metabolic syndrome and related disorders 20110601

Impact of statins on progression of atherosclerosis: rationale and design of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: effect of Rosuvastatin versus AtorvastatiN).

Current medical research and opinion 20110601

Association between obesity, high-sensitivity C-reactive protein ≥2 mg/L, and subclinical atherosclerosis: implications of JUPITER from the Multi-Ethnic Study of Atherosclerosis.

Arteriosclerosis, thrombosis, and vascular biology 20110601

Kinesin-like protein 6 (KIF6) polymorphism and the efficacy of rosuvastatin in primary prevention.

Circulation. Cardiovascular genetics 20110601

Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study.

International journal of clinical practice 20110601

The effects of atorvastatin and rosuvastatin on oxidative stress in diabetic patients.

European journal of internal medicine 20110601

High-sensitivity C-reactive protein, obesity, and subclinical atherosclerosis: implications of JUPITER from the MESA study.

Arteriosclerosis, thrombosis, and vascular biology 20110601

Effect of rosuvastatin on C-reactive protein and progression of aortic stenosis.

American heart journal 20110601

Longitudinal assessment of estimated glomerular filtration rate in apparently healthy adults: a post hoc analysis from the JUPITER study (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).

Clinical therapeutics 20110601

[Effect of OATP1B1 521T --> C heterogenesis on pharmacokinetic characterstics of rosuvastatin in Chinese volunteers].

Yao xue xue bao = Acta pharmaceutica Sinica 20110601

Fish odour syndrome.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20110517

The editor's roundtable: JUPITER follow-up.

The American journal of cardiology 20110515

Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C.

Journal of viral hepatitis 20110501

No effect of rosuvastatin in the zoledronate-induced acute-phase response.

Calcified tissue international 20110501

Statins alleviate experimental nerve injury-induced neuropathic pain.

Pain 20110501

Evaluating optimal lipid levels in patients with mixed dyslipidemia following short- and long-term treatment with fenofibric acid and statin combination therapy: a post hoc analysis.

Current medical research and opinion 20110501

Rosuvastatin prevents myocardial necrosis in an experimental model of acute myocardial infarction.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20110501

The methyl ester of rosuvastatin elicited an endothelium-independent and 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent relaxant effect in rat aorta.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20110501

Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin).

Journal of the American College of Cardiology 20110419

Low coenzyme Q₁₀ levels and the outcome of statin treatment in heart failure.

Journal of the American College of Cardiology 20110405

Improved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9.

Journal of lipid research 20110401

The role of C-reactive protein as a risk predictor of coronary atherosclerosis: implications from the JUPITER trial.

Current atherosclerosis reports 20110401

Different effects of rosuvastatin and simvastatin on myocardial high-energy phosphate metabolism.

International journal of cardiology 20110401

Statins should be used with greater caution in patients undergoing thyroid hormone withdrawal for radioactive iodine treatment.

Thyroid : official journal of the American Thyroid Association 20110401

Rosuvastatin and primary cardiovascular prevention. Continue to use pravastatin or simvastatin.

Prescrire international 20110401

Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis.

BMJ (Clinical research ed.) 20110330

Simultaneous determination of rosuvastatin and atorvastatin in human serum using RP-HPLC/UV detection: method development, validation and optimization of various experimental parameters.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110315

Rosuvastatin lowers coenzyme Q10 levels, but not mitochondrial adenosine triphosphate synthesis, in children with familial hypercholesterolemia.

The Journal of pediatrics 20110301

Rosuvastatin and thapsigargin modulate γ-secretase gene expression and APP processing in a human neuroglioma model.

Journal of molecular neuroscience : MN 20110301

Differential metabolic effects of distinct statins.

Atherosclerosis 20110301

Optimal statin type and dosage for vascular patients.

Journal of vascular surgery 20110301

Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.

Circulation. Heart failure 20110301

Genetics of the coenzyme Q10 pathway and rosuvastatin-induced muscle effects.

The Journal of pediatrics 20110301

Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificity.

Pharmacogenetics and genomics 20110301

Severe rhabdomyolysis due to rosuvastatin in a liver transplant subject with human immunodeficiency virus and immunosuppressive therapy-related dyslipidemia.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20110301

[Effects of rosuvastatin on monocrotaline-induced pulmonary artery hypertension in rats].

Zhonghua xin xue guan bing za zhi 20110301

Low-density lipoprotein cholesterol goal attainment among Malaysian dyslipidemic patients.

The Southeast Asian journal of tropical medicine and public health 20110301

The cost-effectiveness of C-reactive protein testing and rosuvastatin treatment for patients with normal cholesterol levels.

Journal of the American College of Cardiology 20110215

The cost-effectiveness of rosuvastatin therapy JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).

Journal of the American College of Cardiology 20110215

Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study.

International journal of cardiology 20110203

Insulin resistance due to statin therapy: a potential contributor to the negation of statin-induced beneficial effects on cardiac remodelling in heart failure?

International journal of cardiology 20110203

Outcomes of high dose statin loading therapy.

International journal of cardiology 20110203

Small leucine-rich proteoglycans in atherosclerotic lesions: novel targets of chronic statin treatment?

Journal of cellular and molecular medicine 20110201

Rosuvastatin induces apoptosis in CD4(+)CD28 (null) T cells in patients with acute coronary syndromes.

Clinical research in cardiology : official journal of the German Cardiac Society 20110201

Public health impact of statin prescribing strategies based on JUPITER.

Preventive medicine 20110201

Achievement of lipid targets with the combination of rosuvastatin and fenofibric Acid in patients with type 2 diabetes mellitus.

Cardiovascular drugs and therapy 20110201

Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20110201

A crossover study of rosuvastatin and pitavastatin in patients with type 2 diabetes.

Advances in therapy 20110201

Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation.

The American journal of cardiology 20110201

Alternate day rosuvastatin, an underutilized option in statin intolerant hyperlipidemic patients: a case report and literature review.

Tennessee medicine : journal of the Tennessee Medical Association 20110201

Long-term efficacy of adding fenofibric acid to moderate-dose statin therapy in patients with persistent elevated triglycerides.

Cardiovascular drugs and therapy 20110201

eNOS/Hsp70 interaction on rosuvastatin cytoprotective effect in neonatal obstructive nephropathy.

European journal of pharmacology 20110115

High-dose rosuvastatin in chronic heart failure promotes vasculogenesis, corrects endothelial function, and improves cardiac remodeling--results from a randomized, double-blind, and placebo-controlled study.

International journal of cardiology 20110107

12-month follow-up results of high dose rosuvastatin loading before percutaneous coronary intervention in patients with acute coronary syndrome.

International journal of cardiology 20110107

Unending debate: statin dilemma in the management of heart failure.

International journal of cardiology 20110107

Pre-procedural use of statins for all patients undergoing percutaneous coronary intervention.

International journal of cardiology 20110107

Rosuvastatin restored adrenergic and nitrergic function in mesenteric arteries from obese rats.

British journal of pharmacology 20110101

Differential effect of genetic variants of Na(+)-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors.

Xenobiotica; the fate of foreign compounds in biological systems 20110101

Involvement of the p38 pathway in the differential induction of heme oxygenase-1 by statins in Neuro-2A cells exposed to lipopolysaccharide.

Drug and chemical toxicology 20110101

Rosuvastatin for primary prevention in patients with European systematic coronary risk evaluation risk ≥ 5% or Framingham risk >20%: post hoc analyses of the JUPITER trial requested by European health authorities.

European heart journal 20110101

Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia.

Atherosclerosis 20110101

Suppression of Idol expression is an additional mechanism underlying statin-induced up-regulation of hepatic LDL receptor expression.

International journal of molecular medicine 20110101

The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins.

Expert opinion on drug metabolism & toxicology 20110101

Aleglitazar, a balanced PPARα/γ agonist, has no clinically relevant pharmacokinetic interaction with high-dose atorvastatin or rosuvastatin.

Expert opinion on investigational drugs 20110101

Paradoxical decrease in HDL-cholesterol and apolipoprotein A1 with simvastatin and atorvastatin in a patient with type 2 diabetes.

Annals of clinical biochemistry 20110101

Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: the impact of inflammatory process and oxidative stress.

Atherosclerosis 20110101

The risks of a new hypothesis: why did JUPITER patients have almost twice the predicted event rate of reduction?

Journal of cardiovascular medicine (Hagerstown, Md.) 20110101

Race differences: modeling the pharmacodynamics of rosuvastatin in Western and Asian hypercholesterolemia patients.

Acta pharmacologica Sinica 20110101

Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis.

Circulation journal : official journal of the Japanese Circulation Society 20110101

Early intervention with rosuvastatin decreases the lipid components of the plaque in acute coronary syndrome: analysis using integrated backscatter IVUS (ELAN study).

Circulation journal : official journal of the Japanese Circulation Society 20110101

Evaluating the effectiveness of rosuvastatin in preventing the progression of diastolic dysfunction in aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study.

Cardiovascular ultrasound 20110101

A Canadian Critical Care Trials Group project in collaboration with the international forum for acute care trialists - Collaborative H1N1 Adjuvant Treatment pilot trial (CHAT): study protocol and design of a randomized controlled trial.

Trials 20110101

Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly.

Clinical interventions in aging 20110101

Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): the PATROL trial.

Circulation journal : official journal of the Japanese Circulation Society 20110101

Rosuvastatin treatment activates JAK-STAT pathway and increases efficacy of allogeneic mesenchymal stem cell transplantation in infarcted hearts.

Circulation journal : official journal of the Japanese Circulation Society 20110101

[Possible rosuvastatin-induced fatal rhabdomyolysis].

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20110101

Strong statins as the major players for dyslipidemia in high-risk patients: are they all the same or not?

Circulation journal : official journal of the Japanese Circulation Society 20110101

Rhabdomyolysis in an HIV-infected patient with impaired renal function concomitantly treated with rosuvastatin and lopinavir/ritonavir.

Antiviral therapy 20110101

Primary prevention with statins is more cost-effective.

Cardiovascular journal of Africa 20110101

Clinical use and effectiveness of lipid lowering therapies in diabetes mellitus--an observational study from the Swedish National Diabetes Register.

PloS one 20110101

The use of plaque score measurements to assess changes in atherosclerotic plaque burden induced by lipid-lowering therapy over time: the METEOR study.

Journal of atherosclerosis and thrombosis 20110101

Efficacy analysis of the lipid-lowering and renoprotective effects of rosuvastatin in patients with chronic kidney disease.

Endocrine journal 20110101

Rosuvastatin therapy does not affect serum MMP-13 or TIMP-1 levels in hypercholesterolemic patients.

Texas Heart Institute journal 20110101

Effect of atorvastatin vs. rosuvastatin on cardiac sympathetic nerve activity in non-diabetic patients with dilated cardiomyopathy.

Circulation journal : official journal of the Japanese Circulation Society 20110101

Efficacy and tolerability of once-weekly rosuvastatin in patients with previous statin intolerance.

Journal of clinical lipidology 20110101

Concordance between plasma apolipoprotein B levels and cholesterol indices among patients receiving statins and nonstatin treatment: Post-hoc analyses from the U.K. InPractice study.

Journal of clinical lipidology 20110101

Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.

Drug design, development and therapy 20110101

The role of soluble fiber intake in patients under highly effective lipid-lowering therapy.

Nutrition journal 20110101

Clinical usefulness of additional treatment with ezetimibe in patients with coronary artery disease on statin therapy. - From the viewpoint of cholesterol metabolism.-.

Circulation journal : official journal of the Japanese Circulation Society 20110101

Intensive lipid-lowering therapy with rosuvastatin stabilizes lipid-rich coronary plaques. -Evaluation using dual-source computed tomography.-.

Circulation journal : official journal of the Japanese Circulation Society 20110101

A systems biology strategy for predicting similarities and differences of drug effects: evidence for drug-specific modulation of inflammation in atherosclerosis.

BMC systems biology 20110101

Comparative efficacy of ezetimibe/simvastatin, rosuvastatin, and atorvastatin in uncontrolled hyperlipidemia patients.

The American journal of managed care 20110101

Low-dose rosuvastatin improves arterial stiffness in high-risk Japanese patients with dyslipdemia in a primary prevention group.

Circulation journal : official journal of the Japanese Circulation Society 20110101

No evidence for statin-induced proteinuria in healthy volunteers as assessed by proteomic analysis.

Journal of biomedicine & biotechnology 20110101

Effects of lipid-lowering therapy with rosuvastatin on kidney function and oxidative stress in patients with diabetic nephropathy.

Journal of atherosclerosis and thrombosis 20110101

Soybean glycinin improves HDL-C and suppresses the effects of rosuvastatin on hypercholesterolemic rats.

Lipids in health and disease 20110101

Estimating treatment effects for individual patients based on the results of randomised clinical trials.

BMJ (Clinical research ed.) 20110101

Effects of combination therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein (≥ 2 mg/L). cmb@bcm.tmc.edu.

Journal of clinical lipidology 20110101

Effect of rosuvastatin treatment on cholesterol efflux from human macrophages.

Neuro endocrinology letters 20110101

Extreme all-cause mortality in JUPITER requires reexamination of vital records.

Cardiology 20110101

Is chronic severe anemia an independent predictor of poor outcomes?

Cardiology 20110101

[Statins in primary prophylaxis of cardiovascular diseases].

Terapevticheskii arkhiv 20110101

Effects of rosuvastatin versus atorvastatin on rho-associated coiled-coil containing protein kinase activity and endothelial function in patients with atherosclerosis.

The Journal of international medical research 20110101

Statin resistant dyslipidemia in a patient treated with amiodarone.

BMJ case reports 20110101

Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agents.

International journal of cancer 20101215

Trials by independent expert bodies.

Archives of internal medicine 20101213

Letter by Wells and Eisenberg regarding article, 'Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials'.

Circulation 20101207

Letter by Vos et al regarding article, 'Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials'.

Circulation 20101207

Comparative effects of rosuvastatin and allopurinol on circulating levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with chronic heart failure.

International journal of cardiology 20101203

Rosuvastatin and vitamin D: might there be hypovitaminosis D on JUPITER?

International journal of cardiology 20101203

Immunomodulatory effects of rosuvastatin on hepatic ischemia/reperfusion induced injury.

Immunopharmacology and immunotoxicology 20101201

Adding exercise to rosuvastatin treatment: influence on C-reactive protein, monocyte toll-like receptor 4 expression, and inflammatory monocyte (CD14+CD16+) population.

Metabolism: clinical and experimental 20101201

Use of multiple international healthcare databases for the detection of rare drug-associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins.

Pharmacoepidemiology and drug safety 20101201

Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial.

European journal of heart failure 20101201

Efficacy and safety of rosuvastatin 5 mg in combination with fenofibric acid 135 mg in patients with mixed dyslipidemia - a phase 3 study.

Cardiovascular drugs and therapy 20101201

Effect of central obesity, low high-density lipoprotein cholesterol and C-reactive protein polymorphisms on C-reactive protein levels during treatment with Rosuvastatin (10 mg Daily).

The American journal of cardiology 20101201

Characteristics and drug utilization patterns of new users of rosuvastatin and other statins in four countries.

Minerva cardioangiologica 20101201

WT-1 mRNA expression is modulated by nitric oxide availability and Hsp70 interaction after neonatal unilateral ureteral obstruction.

Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al 20101201

HDL cholesterol and residual risk of first cardiovascular events.

Lancet (London, England) 20101120

Rosuvastatin reduces microglia in the brain of wild type and ApoE knockout mice on a high cholesterol diet; implications for prevention of stroke and AD.

Biochemical and biophysical research communications 20101112

No effect of rosuvastatin on left ventricular hypertrophy in patients with hypertension: a prospective randomised open-label study with blinded endpoint assessment.

International journal of cardiology 20101105

Comparison of rosuvastatin and atorvastatin on clopidogrel response and lipidic and inflammatory parameters after coronary stenting for acute coronary syndrome: the prospective, randomized OSCAR study (optimal statin therapy with clopidogrel after coronary revascularisation).

Thrombosis research 20101101

[On the current debate on lowering LDL cholesterol with ezetimibe].

Deutsche medizinische Wochenschrift (1946) 20101101

Impact of baseline plaque components on plaque progression in nonintervened coronary segments in patients with angina pectoris on rosuvastatin 10 mg/day.

The American journal of cardiology 20101101

The JUPITER Trial: responding to the critics.

The American journal of cardiology 20101101

Statin therapy in primary prevention: new insights regarding women and the elderly.

The American journal of cardiology 20101101

Endothelial progenitor cells in patients with acute cerebrovascular ischemia.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20101101

Prevalence of dyslipidemia in statin-treated patients in Canada: results of the DYSlipidemia International Study (DYSIS).

The Canadian journal of cardiology 20101101

Serum levels of C-reactive protein in patients with stable coronary artery disease: JUPITER in perspective.

International journal of cardiology 20101029

High-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosis.

Circulation 20101026

Is diabetes the cost to pay for a greater cardiovascular prevention?

International journal of cardiology 20101008

Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure).

Journal of the American College of Cardiology 20101005

Coenzyme Q10 and statins in heart failure: the dog that didn't bark.

Journal of the American College of Cardiology 20101005

Coadministration of dalcetrapib with pravastatin, rosuvastatin, or simvastatin: no clinically relevant drug-drug interactions.

Journal of clinical pharmacology 20101001

Upregulation of ecto-5'-nucleotidase by rosuvastatin increases the vasodilator response to ischemia.

Hypertension (Dallas, Tex. : 1979) 20101001

Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients.

Pharmacogenetics and genomics 20101001

Change in serum lipids after acute coronary syndromes: secondary analysis of SPACE ROCKET study data and a comparative literature review.

Clinical chemistry 20101001

Effect of increasing doses of Rosuvastatin and Atorvastatin on apolipoproteins, enzymes and lipid transfer proteins involved in lipoprotein metabolism and inflammatory parameters.

Current medical research and opinion 20101001

Lactone pathway to statins utilizing the Wittig reaction. The synthesis of rosuvastatin.

The Journal of organic chemistry 20101001

Rhabdomyolysis induced by rosuvastatin and sildenafil.

Southern medical journal 20101001

Cost-effectiveness of statin therapy for vascular event prevention in adults with elevated C-reactive protein: implications of JUPITER.

Current medical research and opinion 20101001

Case report. Hyperlipoproteinaemia(a): which is the optimal therapy? A case report.

Journal of clinical pharmacy and therapeutics 20101001

Ancestry as a determinant of mean population C-reactive protein values: implications for cardiovascular risk prediction.

Circulation. Cardiovascular genetics 20101001

Combination rosuvastatin plus fenofibric acid in a cohort of patients 65 years or older with mixed dyslipidemia: subanalysis of two randomized, controlled studies.

Clinical cardiology 20101001

Heterozygous familial hypercholesterolemia case study.

Journal of the American Academy of Nurse Practitioners 20101001

Effects of statins on vascular endothelial function in hypercholesterolemic patients with type 2 diabetes mellitus: fluvastatin vs. rosuvastatin.

International journal of cardiology 20100924

Interpreting and evaluating the details of the JUPITER study.

American family physician 20100915

Effect of a single gemfibrozil dose on the pharmacokinetics of rosuvastatin in bile and plasma in healthy volunteers.

Journal of clinical pharmacology 20100901

Rosuvastatin-induced gynaecomastia.

Clinical endocrinology 20100901

The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse.

American journal of physiology. Renal physiology 20100901

Rosuvastatin added to standard heart failure therapy improves cardiac remodelling in heart failure rats with preserved ejection fraction.

European journal of heart failure 20100901

Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer.

European urology 20100901

Impact of restricted reimbursement on the use of statins in Finland: a register-based study.

Medical care 20100901

Rosuvastatin for primary prevention among individuals with elevated high-sensitivity c-reactive protein and 5% to 10% and 10% to 20% 10-year risk. Implications of the Justification for Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial for 'intermediate risk'.

Circulation. Cardiovascular quality and outcomes 20100901

Relationship between bicuspid aortic valve morphology and aortic wall degeneration: further evidence is emerging.

Echocardiography (Mount Kisco, N.Y.) 20100901

Statin loading before percutaneous coronary intervention: proposed mechanisms and applications.

Future cardiology 20100901

[Rosuvastatin enhances the protective effects of ischemic postconditioning on myocardial ischaemia-reperfusion injury in type 2 diabetic rat].

Zhonghua xin xue guan bing za zhi 20100901

[Role of rosuvastatin in current lipid-lowering therapy].

Orvosi hetilap 20100829

C-reactive protein lowering with rosuvastatin in the METEOR study.

Journal of internal medicine 20100801

Antioxidant, antinociceptive and anti-inflammatory activities of atorvastatin and rosuvastatin in various experimental models.

Inflammopharmacology 20100801

The effect of acute administration of rifampicin and imatinib on the enterohepatic transport of rosuvastatin in vivo.

Xenobiotica; the fate of foreign compounds in biological systems 20100801

Improved cardiac performance by rosuvastatin is associated with attenuations in both myocardial tumor necrosis factor-alpha and p38 MAP kinase activity in rats after myocardial infarction.

The American journal of the medical sciences 20100801

Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial.

American heart journal 20100801

Statin therapy for elevated hsCRP: what are the public health implications?

The American journal of managed care 20100801

Statin therapy for elevated hsCRP: more evidence is needed.

The American journal of managed care 20100801

Was the FDA misled by JUPITER?

The Journal of the American Osteopathic Association 20100801

Cost-effectiveness of rosuvastatin for primary prevention of cardiovascular events according to Framingham Risk Score in patients with elevated C-reactive protein.

The Journal of the American Osteopathic Association 20100801

HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial.

Lancet (London, England) 20100731

Rosuvastatin preconditioning provides neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressions.

Brain research 20100730

Homozygous familial hypercholesterolaemia and treatment by LDL apheresis.

The New Zealand medical journal 20100730

Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER).

The American journal of cardiology 20100715

Rosuvastatin stimulates clonogenic potential and anti-inflammatory properties of endothelial progenitor cells.

Cell biology international 20100701

Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, increases survival in stroke-prone rats by preventing systemic inflammation and endothelial dysfunction: comparison with aspirin and rosuvastatin.

The Journal of pharmacology and experimental therapeutics 20100701

Expression of the hepatic Niemann-Pick C1 like 1 protein gene is sensitive to rosuvastatin treatment of primary human hepatocytes.

Pharmacogenetics and genomics 20100701

Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets.

International journal of clinical practice 20100701

Imperfect pharmacovigilance.

Southern medical journal 20100701

Rosuvastatin-induced thrombocytopenia.

Southern medical journal 20100701

Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?

Pharmacogenomics 20100701

Cholesterol lowering, cardiovascular diseases, and the rosuvastatin-JUPITER controversy: a critical reappraisal.

Archives of internal medicine 20100628

Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering.

International journal of cardiology 20100625

JUPITER, rosuvastatin, and the European Medicines Agency.

Lancet (London, England) 20100612

Rosuvastatin protects tissue perfusion in the experimental testicular torsion model.

International urology and nephrology 20100601

Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters.

Journal of lipid research 20100601

Effects of atorvastatin 20 mg, rosuvastatin 10 mg, and atorvastatin/ezetimibe 5 mg/5 mg on lipoproteins and glucose metabolism.

Journal of cardiovascular pharmacology and therapeutics 20100601

Hepatic metabolism and transporter gene variants enhance response to rosuvastatin in patients with acute myocardial infarction: the GEOSTAT-1 Study.

Circulation. Cardiovascular genetics 20100601

Glucose-regulated protein 78 and platelet deposition: effect of rosuvastatin.

Arteriosclerosis, thrombosis, and vascular biology 20100601

Acute renal failure with the combined use of rosuvastatin and fenofibrate.

Renal failure 20100601

Effects of three strong statins (atorvastatin, pitavastatin, and rosuvastatin) on serum uric acid levels in dyslipidemic patients.

Nucleosides, nucleotides & nucleic acids 20100601

[The AURORA study].

Giornale italiano di cardiologia (2006) 20100601

Highly stereoselective hydrogenations--as key-steps in the total synthesis of statins.

Chirality 20100515

Effects of rosuvastatin on myeloperoxidase levels in patients with chronic heart failure: a randomized placebo-controlled study.

Atherosclerosis 20100501

Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes.

Atherosclerosis 20100501

ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatin.

Clinical pharmacology and therapeutics 20100501

Reversal of age-associated memory impairment by rosuvastatin in rats.

Experimental gerontology 20100501

Cost-effectiveness of rosuvastatin versus ezetimibe/simvastatin in managing dyslipidemic patients in Mexico.

Current medical research and opinion 20100501

By the way, doctor. I take a fiber supplement, but have heard that I shouldn't be taking it at the same times as medication. How far apart should I take fiber and medicines such as Plavix and Crestor?

Harvard health letter 20100501

Can intensive lipid-lowering therapy with statins ameliorate atherosclerosis in Japanese patients? Rationale and design of the JART study.

Journal of atherosclerosis and thrombosis 20100430

Summaries for patients. Rosuvastatin to prevent heart problems and stroke in persons 70 years or older.

Annals of internal medicine 20100420

Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial.

Annals of internal medicine 20100420

Statins for primary prevention in older adults: who is high risk, who is old, and what denotes primary prevention?

Annals of internal medicine 20100420

Rosuvastatin and cardiovascular continuum when time is important.

Journal of the American College of Cardiology 20100413

FDA approves a statin therapy for some: certain, asymptomatic individuals targeted.

JAMA 20100407

In vivo performance of absorbable collagen sponges with rosuvastatin in critical-size cortical bone defects.

Acta biomaterialia 20100401

Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study.

European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 20100401

Use of a combination of prednisolone and rosuvastatin for treatment of a pyogranuloma in a dog.

Journal of the American Veterinary Medical Association 20100401

Should we measure C-reactive protein on earth or just on JUPITER?

Clinical cardiology 20100401

Enhanced effect of losartan and rosuvastatin on neointima hyperplasia.

Archives of pharmacal research 20100401

Achieving treatment goals in low-risk, asymptomatic patients.

The Journal of the American Osteopathic Association 20100401

New analysis supports expanded use of statins in women.

Harvard women's health watch 20100401

Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial.

Journal of the American College of Cardiology 20100323

Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia.

Journal of the American College of Cardiology 20100316

Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials.

Circulation 20100309

The numbers are in: statins for the primary prevention of cardiovascular disease in women.

Circulation 20100309

Rosuvastatin prevents conduit artery endothelial dysfunction induced by ischemia and reperfusion by a cyclooxygenase-2-dependent mechanism.

Journal of the American College of Cardiology 20100309

Biliary efflux transporters involved in the clearance of rosuvastatin in sandwich culture of primary rat hepatocytes.

Toxicology in vitro : an international journal published in association with BIBRA 20100301

Comparison of sequential rosuvastatin doses in hypercholesterolaemia: a meta-analysis of randomised controlled trials.

Current medical research and opinion 20100301

Signal detection of rosuvastatin compared to other statins: data-mining study using national health insurance claims database.

Pharmacoepidemiology and drug safety 20100301

Persistent regional diastolic dysfunction after myocardial ischemia and the effect of statin treatment: assessment with two-dimensional radial strain rate.

Echocardiography (Mount Kisco, N.Y.) 20100301

Comparative study of low doses of rosuvastatin and atorvastatin on lipid and glycemic control in patients with metabolic syndrome and hypercholesterolemia.

The Korean journal of internal medicine 20100301

Interpreting the JUPITER trial: statins can prevent VTE, but more study is needed.

Cleveland Clinic journal of medicine 20100301

The effects of rosuvastatin on the serum cortisol, serum lipid, and serum mevalonic acid levels in the healthy Indian male population.

AAPS PharmSciTech 20100301

[Effects of rosuvastatin on left ventricular cardiac function, arteriosclerotic plaque and high sensitive C-reactive protein in hypertensive patients with mild LDL-C elevation].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20100301

Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study.

Clinical therapeutics 20100301

Pharmacokinetics of rosuvastatin in healthy Chinese volunteers living in China: a randomized, open-label, ascending single- and multiple-dose study.

Clinical therapeutics 20100301

Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: results of the CENTAURUS study.

Archives of cardiovascular diseases 20100301

Effects of rosuvastatin on coronary flow reserve and metabolic mismatch in patients with heart failure (from the CORONA Study).

The American journal of cardiology 20100215

Rosuvastatin inhibits norepinephrine-induced cardiac hypertrophy via suppression of Gh.

European journal of pharmacology 20100210

Human skeletal muscle drug transporters determine local exposure and toxicity of statins.

Circulation research 20100205

Association of Bicuspid aortic valve morphology and aortic root dimensions: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study.

Echocardiography (Mount Kisco, N.Y.) 20100201

Prescribing statins in aortic stenosis: little to lose, much to gain.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20100201

Ammonium methacrylate units polymer content and their effect on acyclovir colloidal nanoparticles properties and bioavailability in human volunteers.

Colloids and surfaces. B, Biointerfaces 20100201

The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy.

The pharmacogenomics journal 20100201

Rosuvastatin induces delayed preconditioning against L-glutamate excitotoxicity in cultured cortical neurons.

Neurochemistry international 20100201

Measuring hsCRP--an important part of a comprehensive risk profile or a clinically redundant practice?

PLoS medicine 20100201

Prevention of peri-procedural myocardial injury using a single high loading dose of rosuvastatin.

Cardiovascular drugs and therapy 20100201

Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial.

Circulation 20100119

Public health. U.S. panel favors wider use of preventive drug treatment.

Science (New York, N.Y.) 20100108

Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER).

Circulation 20100105

Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial.

AIDS (London, England) 20100102

Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier.

Drug metabolism and disposition: the biological fate of chemicals 20100101

Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis.

Diabetes research and clinical practice 20100101

Year two assessment of fenofibric acid and moderate-dose statin combination: a phase 3, open-label, extension study.

Clinical drug investigation 20100101

An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial.

European journal of heart failure 20100101

Earth to JUPITER: how a potent statin may actually be detrimental for lifestyle-associated diseases.

Angiology 20100101

HMG-CoA reductase inhibitor improves endothelial dysfunction in spontaneous hypertensive rats via down-regulation of caveolin-1 and activation of endothelial nitric oxide synthase.

Journal of Korean medical science 20100101

Meta-analysis of comparative efficacy of increasing dose of Atorvastatin versus Rosuvastatin versus Simvastatin on lowering levels of atherogenic lipids (from VOYAGER).

The American journal of cardiology 20100101

Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia.

American journal of cardiovascular drugs : drugs, devices, and other interventions 20100101

One-year treatment with rosuvastatin reduces intima-media thickness in 45 hypercholesterolemic subjects with asymptomatic carotid artery disease.

Pharmacology 20100101

Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.

American journal of cardiovascular drugs : drugs, devices, and other interventions 20100101

Effect of rosuvastatin on cholestasis-induced hepatic injury in rat livers.

Journal of biochemical and molecular toxicology 20100101

[Non-ST-elevation acute coronary syndrome. Comparison of effects of atorvastatin and rosuvastatin on blood levels of lipids and markers of inflammation].

Kardiologiia 20100101

Efficacy and safety of ezetimibe for Japanese patients with dyslipidaemia: The ESSENTIAL Study.

Clinical drug investigation 20100101

Cardiovascular risk in uremic patients: darkness after AURORA.

Renal failure 20100101

Is Jupiter also a god of primary prevention?

Texas Heart Institute journal 20100101

The Post-JUPITER trial era and the cost of preventive medicine.

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 20100101

From CARDS to AURORA: one disease, two responses.

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 20100101

Pharmacokinetic/pharmacodynamic modeling and simulation of rosuvastatin using an extension of the indirect response model by incorporating a circadian rhythm.

Biological & pharmaceutical bulletin 20100101

Efficacy and safety of rosuvastatin and fenofibric acid combination therapy versus simvastatin monotherapy in patients with hypercholesterolemia and hypertriglyceridemia: a randomized, double-blind study.

American journal of cardiovascular drugs : drugs, devices, and other interventions 20100101

Cost effectiveness of rosuvastatin in patients at risk of cardiovascular disease based on findings from the JUPITER trial.

Journal of medical economics 20100101

The endothelial-protective effects of HMG-CoA reductase inhibition in the setting of ischemia and reperfusion injury.

Clinical hemorheology and microcirculation 20100101

Determination of rosuvastatin and ezetimibe in a combined tablet dosage form using high-performance column liquid chromatography and high-performance thin-layer chromatography.

Journal of AOAC International 20100101

Ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency.

Lipids in health and disease 20100101

Rosuvastatin promotes osteoblast differentiation and regulates SLCO1A1 transporter gene expression in MC3T3-E1 cells.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20100101

Rosuvastatin: a review of its use in the prevention of cardiovascular disease in apparently healthy women or men with normal LDL-C levels and elevated hsCRP levels.

American journal of cardiovascular drugs : drugs, devices, and other interventions 20100101

A case report of a diabetic woman with very low HDL cholesterol.

Journal of clinical lipidology 20100101

Complete Apo AI deficiency in an Iraqi Mandaean family: case studies and review of the literature.

Journal of clinical lipidology 20100101

Switching from high-efficacy lipid-lowering therapies to simvastatin and low-density lipoprotein cholesterol goal attainment in coronary heart disease/coronary heart disease-equivalent patients.

Journal of clinical lipidology 20100101

Rosuvastatin reduces neointima formation in a rat model of balloon injury.

European journal of medical research 20100101

Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective.

Drug design, development and therapy 20100101

Hepatic lipase deficiency in a Middle-Eastern-Arabic male.

BMJ case reports 20100101

Clinical efficacy of rosuvastatin in lipid management in Chinese patients in Hong Kong.

Chinese medical journal 20091205

Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1.

Journal of cardiovascular pharmacology and therapeutics 20091201

A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial.

European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 20091201

Enterohepatic disposition of rosuvastatin in pigs and the impact of concomitant dosing with cyclosporine and gemfibrozil.

Drug metabolism and disposition: the biological fate of chemicals 20091201

Effectiveness of rosuvastatin compared to other statins for the prevention of cardiovascular events-a cohort study in 395 039 patients from clinical practice.

Pharmacoepidemiology and drug safety 20091201

Rediscovering bile acid sequestrants.

Diabetes, obesity & metabolism 20091201

Effects of rosuvastatin on asymmetric dimethylarginine levels and early atrial fibrillation recurrence after electrical cardioversion.

Pacing and clinical electrophysiology : PACE 20091201

Usefulness of aggressive lipid-lowering therapy with rosuvastatin in hypercholesterolemic patients with concomitant type 2 diabetes.

Endocrine 20091201

Effect of simvastatin vs. rosuvastatin on adiponectin and haemoglobin A1c levels in patients with non-ischaemic chronic heart failure.

European journal of heart failure 20091201

Effect of targeting mitogen-activated protein kinase on cardiac remodeling in rats.

Journal of cardiovascular pharmacology and therapeutics 20091201

Effectiveness of rosuvastatin in reducing LDL-C and target LDL-C goal attainment in real-world clinical practice.

Current medical research and opinion 20091201

Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis.

Circulation 20091201

Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category.

Metabolic syndrome and related disorders 20091201

Another look at the results of the JUPITER trial.

The American journal of cardiology 20091201

Pharmacokinetics of rosuvastatin in patients with end-stage kidney disease undergoing peritoneal dialysis.

Clinical nephrology 20091201

Clinical trial update II: Jupiter trial, rosuvastatin has greater efficacy in elderly populations.

European heart journal 20091201

Efficacy of combination drug pulse therapy in maintaining lipid levels in patients intolerant of daily statin use.

Journal of clinical hypertension (Greenwich, Conn.) 20091201

[The JUPITER study: background and research hypotheses].

Giornale italiano di cardiologia (2006) 20091201

[The JUPITER study: critical review of final results].

Giornale italiano di cardiologia (2006) 20091201

[JUPITER, what now?].

Giornale italiano di cardiologia (2006) 20091201

The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome.

International journal of cardiology 20091112

Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).

Journal of the American College of Cardiology 20091110

Can natriuretic peptides help identify heart failure patients for whom statins are beneficial?

Journal of the American College of Cardiology 20091110

Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment.

Journal of internal medicine 20091101

Comparison of incidences of cardiovascular events among new users of different statins: a retrospective observational cohort study.

Current medical research and opinion 20091101

Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS).

Circulation journal : official journal of the Japanese Circulation Society 20091101

Cosmic effect of rosuvastatin in COSMOS.

Circulation journal : official journal of the Japanese Circulation Society 20091101

Efficacy of aggressive lipid controlling therapy for preventing saphenous vein graft disease.

The Annals of thoracic surgery 20091101

[From lipid target values to the JUPITER study. Significance of achieving lipid levels specified by the guidelines and deficiencies in practice].

Orvosi hetilap 20091101

Occurrence and fate of rosuvastatin, rosuvastatin lactone, and atorvastatin in Canadian sewage and surface water samples.

Chemosphere 20091101

Rosuvastatin along the cardiovascular continuum: from JUPITER to AURORA.

Expert review of cardiovascular therapy 20091101

Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).

Circulation. Cardiovascular quality and outcomes 20091101

Rosuvastatin attenuates heart failure and cardiac remodelling in the ageing spontaneously hypertensive rat.

Basic & clinical pharmacology & toxicology 20091001

Cardiac hypertrophy during hypercholesterolemia and its amelioration with rosuvastatin and amlodipine.

Journal of cardiovascular pharmacology 20091001

Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial.

European heart journal 20091001

Effects of a 3-month course of rosuvastatin in patients with systemic lupus erythematosus.

Annals of the rheumatic diseases 20091001

Effect of the HMG-CoA reductase inhibitor rosuvastatin on early chronic kidney injury in obese zucker rats fed with an atherogenic diet.

The American journal of the medical sciences 20091001

[The role of statins in the treatment of heart failure].

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir 20091001

[C-reactive protein and coronary heart disease: quo vadis?].

MMW Fortschritte der Medizin 20091001

Statins and angiogenesis: is it about connections?

Biochemical and biophysical research communications 20090925

[Sympathetic nerve in rat with pressure overload left ventricular hypertrophy].

Zhonghua yi xue za zhi 20090915

Effects of rosuvastatin on electronegative LDL as characterized by capillary isotachophoresis: the ROSARY Study.

Journal of lipid research 20090901

Induction of RISK by HMG-CoA reductase inhibition affords cardioprotection after myocardial infarction.

Atherosclerosis 20090901

Effect of rosuvastatin on cardiac remodeling, function, and progression to heart failure in hypertensive heart with established left ventricular hypertrophy.

Hypertension (Dallas, Tex. : 1979) 20090901

Rosuvastatin ameliorates the development of pulmonary arterial hypertension in the transgenic (mRen2)27 rat.

American journal of physiology. Heart and circulatory physiology 20090901

Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose.

International journal of clinical practice 20090901

Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study.

Expert review of cardiovascular therapy 20090901

[To treat or not to treat with statins patients with chronic heart failure?].

Vnitrni lekarstvi 20090901

Most would fail to benefit from JUPITER Intervention.

Journal of the American College of Cardiology 20090818

Effects of rosuvastatin on platelet inhibition by clopidogrel in cardiovascular patients.

Journal of thrombosis and thrombolysis 20090801

Insights into atherosclerosis from invasive and non-invasive imaging studies: Should we treat subclinical atherosclerosis?

Atherosclerosis 20090801

The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.

Therapeutic advances in cardiovascular disease 20090801

ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin.

Clinical pharmacology and therapeutics 20090801

Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins?

Cardiovascular drugs and therapy 20090801

Severe HIV-associated hypertriglyceridaemia treated with rosuvastatin plus omega-3 fatty acids.

International journal of STD & AIDS 20090801

Alternate day dosing of rosuvastatin: potential usefulness in statin-intolerant patients.

The Canadian journal of cardiology 20090801

No significant effect of ABCB1 haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin.

British journal of clinical pharmacology 20090801

Effects of rosuvastatin on low-density lipoprotein cholesterol and plasma lipids in Asian patients with hypercholesterolemia.

Journal of atherosclerosis and thrombosis 20090801

Rosuvastatin for cardiovascular prevention: too many uncertainties.

Prescrire international 20090801

[Significance of determination of lipid-oxidizing catalytic antibodies in patients with ischemic heart diseases].

Klinicheskaia laboratornaia diagnostika 20090801

Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.

Lancet (London, England) 20090704

Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.

Lancet (London, England) 20090704

Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.

Lancet (London, England) 20090704

Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.

Lancet (London, England) 20090704

Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.

Lancet (London, England) 20090704

Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.

Lancet (London, England) 20090704

Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.

Lancet (London, England) 20090704

Rosuvastatin in patients undergoing hemodialysis.

The New England journal of medicine 20090702

Rosuvastatin in patients undergoing hemodialysis.

The New England journal of medicine 20090702

Rosuvastatin in patients undergoing hemodialysis.

The New England journal of medicine 20090702

Rosuvastatin reduces atherosclerotic lesions and promotes progenitor cell mobilisation and recruitment in apolipoprotein E knockout mice.

Atherosclerosis 20090701

Effects of intensive atorvastatin and rosuvastatin treatment on apolipoprotein B-48 and remnant lipoprotein cholesterol levels.

Atherosclerosis 20090701

Adding exercise training to rosuvastatin treatment: influence on serum lipids and biomarkers of muscle and liver damage.

Metabolism: clinical and experimental 20090701

Moving toward new statin guidelines in a post-JUPITER world: principles to consider.

Current atherosclerosis reports 20090701

Statins and venous thromboembolism: a novel effect of statins?

Current medical research and opinion 20090701

The Jupiter trial--new territory for statins?

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20090701

Statin therapy in patients with heart failure and preserved left ventricular function.

Circulation journal : official journal of the Japanese Circulation Society 20090701

Safety and efficacy of achieving very low low-density lipoprotein cholesterol levels with rosuvastatin 40 mg daily (from the ASTEROID Study).

The American journal of cardiology 20090701

Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial.

Expert review of cardiovascular therapy 20090701

Statins and cardiovascular events in patients with end-stage renal disease on hemodialysis. The AURORA results suggest the need for earlier intervention.

Current vascular pharmacology 20090701

Attenuated plaque at nonculprit lesions in patients enrolled in intravascular ultrasound atherosclerosis progression trials.

JACC. Cardiovascular interventions 20090701

Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis.

JACC. Cardiovascular interventions 20090701

Can statins alter coronary plaque composition assessed by radiofrequency backscatter intravascular ultrasound?

JACC. Cardiovascular interventions 20090701

Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice.

Archives of medical research 20090701

Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes.

Journal of lipid research 20090601

Effects of rosuvastatin and atorvastatin on LDL and HDL particle concentrations in patients with metabolic syndrome: a randomized, double-blind, controlled study.

Diabetes care 20090601

Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study.

Journal of internal medicine 20090601

Rosuvastatin increases extracellular adenosine formation in humans in vivo: a new perspective on cardiovascular protection.

Arteriosclerosis, thrombosis, and vascular biology 20090601

The effect of rosuvastatin on insulin sensitivity and pancreatic beta-cell function in nondiabetic renal transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20090601

[The JUPITER study emphasizes primary prevention].

Lakartidningen 20090601

The influence of rosuvastatin therapy and percutaneous coronary intervention on angiogenic growth factors in coronary artery disease patients.

Acta cardiologica 20090601

[The JUPITER study poses more questions than answers].

Lakartidningen 20090601

[JUPITER--think first, act subsequently!].

Lakartidningen 20090601

[Treat the primary cause of inflammation in overweight individuals without symptoms of coronary disease].

Lakartidningen 20090601

Automated liquid-liquid extraction method for high-throughput analysis of rosuvastatin in human EDTA K2 plasma by LC-MS/MS.

Bioanalysis 20090601

The editor's roundtable: the JUPITER trial--initial results and clinical implications.

The American journal of cardiology 20090515

Improved pharmacokinetic and bioavailability support of drug discovery using serial blood sampling in mice.

Journal of pharmaceutical sciences 20090501

LDL-cholesterol lowering increases plasma apelin in isolated hypercholesterolemia.

Atherosclerosis 20090501

Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: a phase 3 study.

Atherosclerosis 20090501

Exaggerated benefits of rosuvastatin compared with other statins.

Pharmacoepidemiology and drug safety 20090501

Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?

Advances in therapy 20090501

The gravity of JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin).

Postgraduate medicine 20090501

[The JUPITER study].

Giornale italiano di cardiologia (2006) 20090501

[JUPITER no support of changed guidelines for cardiovascular prevention. Moderate absolute risk reduction and uncertain long term effects].

Lakartidningen 20090501

[JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor].

Lakartidningen 20090501

Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk.

Future cardiology 20090501

The JUPITER trial: results, controversies, and implications for prevention.

Circulation. Cardiovascular quality and outcomes 20090501

JUPITER: a few words of caution.

Circulation. Cardiovascular quality and outcomes 20090501

A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

The New England journal of medicine 20090430

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.

Lancet (London, England) 20090404

Bringing JUPITER down to earth.

Lancet (London, England) 20090404

Lipid lowering for primary prevention.

Lancet (London, England) 20090404

Sunset for statins after AURORA?

The New England journal of medicine 20090402

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

The New England journal of medicine 20090402

Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers.

Journal of lipid research 20090401

Effect of atorvastatin versus rosuvastatin on levels of serum lipids, inflammatory markers and adiponectin in patients with hypercholesterolemia.

Pharmaceutical research 20090401

Impact of a compliance program on cholesterol control: results of the randomized ORBITAL study in 8108 patients treated with rosuvastatin.

European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 20090401

Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.

International journal of clinical practice 20090401

Study stirs debate about statin use in those without high cholesterol.

Mayo Clinic women's healthsource 20090401

Effects of rosuvastatin and colestimide on metabolic parameters and urinary monocyte chemoattractant protein-1 in type 2 diabetic patients with hyperlipidemia.

Southern medical journal 20090401

[Rosuvastatin in patients with chronic heart failure].

Der Internist 20090401

Using statins to treat 'healthy' patients: are we there yet?

Expert review of pharmacoeconomics & outcomes research 20090401

[The JUPITER trial: a new approach in primary prevention].

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir 20090401

Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) study.

Journal of the American College of Cardiology 20090317

JUPITER clinical directions--polling results.